0001575872-23-000819.txt : 20230522 0001575872-23-000819.hdr.sgml : 20230522 20230522172030 ACCESSION NUMBER: 0001575872-23-000819 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GoLogiq, Inc. CENTRAL INDEX KEY: 0001746278 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 352618297 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 333-231286 FILM NUMBER: 23945661 BUSINESS ADDRESS: STREET 1: 85 BROAD STREET, 16-079 CITY: NEW YORK STATE: NY ZIP: 10004 BUSINESS PHONE: 8088291057 MAIL ADDRESS: STREET 1: 85 BROAD STREET, 16-079 CITY: NEW YORK STATE: NY ZIP: 10004 FORMER COMPANY: FORMER CONFORMED NAME: LOVARRA DATE OF NAME CHANGE: 20180712 10-Q 1 golq-20230331.htm FORM 10-Q GoLogiq, Inc.
--12-31false0001746278Q1 0001746278 2023-03-31 0001746278 2022-12-31 0001746278 2023-01-01 2023-03-31 0001746278 2022-01-01 2022-03-31 0001746278 2022-07-27 2022-07-27 0001746278 2022-04-01 2022-04-01 0001746278 2022-01-27 2022-01-27 0001746278 2022-07-26 2022-07-26 0001746278 2023-05-12 0001746278 2023-03-07 0001746278 2023-03-07 2023-03-07 0001746278 2021-12-31 0001746278 2022-03-31 0001746278 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001746278 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001746278 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001746278 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001746278 golq:BusinessCombinationMember 2023-03-31 0001746278 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-03-31 0001746278 us-gaap:CommonStockMember 2023-03-31 0001746278 golq:LogiqIncMember 2022-01-27 0001746278 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-27 0001746278 us-gaap:SeriesAPreferredStockMember 2022-07-26 2022-07-26 0001746278 us-gaap:SeriesAPreferredStockMember 2022-07-26 0001746278 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-27 2022-01-27 0001746278 golq:CreateAppPlatformMember 2023-02-28 0001746278 us-gaap:CommonStockMember 2023-03-07 2023-03-07 0001746278 us-gaap:SeriesAPreferredStockMember 2023-03-07 0001746278 golq:NesteggMember us-gaap:CommonStockMember 2023-01-30 0001746278 us-gaap:CommonStockMember 2022-12-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001746278 golq:ShareSubscriptionsReceivableMember 2022-12-31 0001746278 us-gaap:RetainedEarningsMember 2022-12-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001746278 golq:ShareSubscriptionsReceivableMember 2023-03-31 0001746278 us-gaap:RetainedEarningsMember 2023-03-31 0001746278 us-gaap:CommonStockMember 2021-12-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001746278 golq:ShareSubscriptionsReceivableMember 2021-12-31 0001746278 us-gaap:RetainedEarningsMember 2021-12-31 0001746278 us-gaap:CommonStockMember 2022-03-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001746278 golq:ShareSubscriptionsReceivableMember 2022-03-31 0001746278 us-gaap:RetainedEarningsMember 2022-03-31 iso4217:USD xbrli:shares utr:Year xbrli:pure iso4217:USD xbrli:shares
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549
 
FORM 10-Q
 
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended March 31, 2023
 
or
 
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _________ to _________
 
Commission file number: 333-231286
 
GoLogiq, Inc.
(Exact name of registrant as specified in its charter)
 
Nevada
 
35-2618297
(State or other jurisdiction of

incorporation or organization)
 
(I.R.S. Employer

Identification No.)
 
 
 
230 Victoria Street Bugis Junction

#15-01/08, Singapore 188024
 
+65 9366 2322
(Address of principal executive offices including zip code)
 
(Registrant’s telephone number, including area code)
SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
 
Title of Each Class
 
Trading Symbol(s)
 
Name of Each Exchange on Which Registered
None
 
N/A
 
N/A
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes 
  No 
 
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes 
  No 
 
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated Filer 
Accelerated Filer 
Non-accelerated Filer
 
Smaller reporting company 
Emerging growth company 
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. 
 
Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. 
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes 
 No 
 
As of May
12
, 2023,
 
129,677,156 shares of the registrant’s common stock were issued and outstanding.

 

 

GoLogiq, Inc.
QUARTERLY REPORT ON FORM 10-Q
 
INDEX TO FINANCIAL STATEMENTS
 

 

 














 
 

 

 

 







 
 


 
i
 

PART I – FINANCIAL INFORMATION
 
Item 1.  Financial Statements
 
The accompanying interim condensed financial statements of GoLogiq, Inc. (“the Company,” “we,” “us” or “our”), have been prepared without audit pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures normally included in financial statements prepared in accordance with United States generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations.
 
The interim condensed financial statements are condensed and should be read in conjunction with the Company’s latest annual financial statements.
 
In the opinion of management, the interim condensed financial statements contain all material adjustments, consisting only of normal adjustments considered necessary to present fairly the financial condition, results of operations, and cash flows of the Company for the interim periods presented.

 
1
 
GoLogiq, Inc.
Balance Sheets
(Expressed in U.S. dollars)
 
 
 
March 31, 2023
 
 
December 31, 2022
 
 
$
 
 
$
 
 
 
 
 
 
 
 
ASSETS
 
 
 
 
 
 
 
Current Assets
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
 
115,498
 
 
 
35,254
 
Intangible assets, net
 
 
8,968,000
 
 
 
8,968,000
 
Goodwill
 
 
2,832,000
 
 
 
2,832,000
 
TOTAL ASSETS
 
 
11,915,498
 
 
 
11,835,254
 
LIABILITIES AND STOCKHOLDER’S DEFICIT
 
 
 
 
 
 
 
Current Liabilities
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
 
 
1,159,651
 
 
 
1,321,483
 
Due to a related party
 
 
597,385
 
 
 
788,045
 
Total Liabilities
 
 
1,757,036
 
 
 
2,109,528
 
Stockholder’s Funds (Deficit)
 
 
 
 
 
 
 
Common stock Authorized: 200,000,000 shares of common stock, $0.001 par value 124,609,635 and 40,444,083 shares issued and outstanding as of March 21, 2023 and December 31, 2022, respectively
 
 
124,610
 
 
 
40,444
 
Preferred stock Authorized: 10,000,000 shares of preferred stock, 2,000,000 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively
 
 
2,000
 
 
 
2,000
 
Additional paid-in capital
 
 
36,273,995
 
 
 
34,003,212
 
Share subscriptions receivable
 
 
(58
)
 
 
(58
)
Accumulated deficit
 
 
(26,242,085
)
 
 
(24,319,872
)
Total Stockholder’s Funds
 
 
10,158,462
 
 
 
9,725,726
 
TOTAL LIABILITIES AND STOCKHOLDER’S FUNDS
 
 
11,915,498
 
 
 
11,835,254
 
 
(The accompanying notes are an integral part of these financial statements)
 
2
 
GoLogiq, Inc.

Statements of Operations and Comprehensive Loss

(Expressed in U.S. dollars)
 
 
 
Three months ended
 
 
Three months ended
 
 
 
March 31, 2023
 
 
March 31, 2022
 
 
$
 
 
$
 
 
 
 
 
 
 
 
Service Revenue
 
 
71,916
 
 
 
3,309,017
 
Cost of Service
 
 
38,645
 
 
 
2,235,341
 
Gross Profit
 
 
33,271
 
 
 
1,073,676
 
Operating Expenses
 
 
 
 
 
 
 
General and administrative
 
 
1,900,484
 
 
 
1,368,799
 
Sales and marketing
 
 
-
 
 
 
5,000
 
Impairment loss
 
 
-
 
 
 
-
 
Research and development
 
 
55,000
 
 
 
1,090,500
 
Total Operating Expenses
 
 
1,955,484
 
 
 
2,464,299
 
(Loss) from Operations
 
 
(1,922,213
)
 
 
(1,390,623
)
Income tax (Corporate tax)
 
 
-
 
 
 
-
 
Net (Loss) and Comprehensive (Loss)
 
 
(1,922,213
)
 
 
(1,390,623
)
Basic and Diluted Net (Loss) per Common Share
 
 
(0.037
)
 
 
(0.052
)
Weighted Average Number of Common Shares Outstanding
 
 
51,477,398
 
 
 
26,637,863
 
 
(The accompanying notes are an integral part of these financial statements)
 
3
 
GoLogiq, Inc.
Statements of
Stockholder’s Equity
(Deficit)
(Expressed in U.S. dollars)
 
 
 
Common Stock
 
 
Additional
Paid-in Capital
 
 
 
 
Share
Subscription
Receivable
 
 
 
 
 
 
Accumulated
Deficit
 
 
 
 
Total
Stockholders’
Equity (Deficit)
 
 
 
 
 
Number of

Shares
 
 
Amount

$
 
 
$
 
 
$
 
 
$
 
 
$
 
Balance, December 31, 2022
 
 
40,444,083
 
 
 
42,444
 
 
 
34,003,212
 
 
 
(58
)
 
 
(24,319,872
)
 
 
9,725,726
 
Issuance of Shares
 
 
76,936,479
 
 
 
76,937
 
 
 
2,270,783
 
 
 
-
 
 
 
-
 
 
 
2,347,720
 
Issuance of Shares for service
 
 
7,229,073
 
 
 
7,229
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
7,229
 
Net (loss) for the year
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(1,922,213
)
 
 
(1,922,213
)
Balance, March 31, 2023
 
 
124,609,635
 
 
 
126,610
 
 
 
36,273,995
 
 
 
(58
)
 
 
(26,242,085
)
 
 
10,158,462
 
 
 
 
 
 
Common Stock
 
 
Additional

Paid-in Capital
 
 
Share
Subscription
Receivable
 
 
 
 
 
 
Accumulated
Deficit
 
 
 
 
Total
Stockholders’
Equity (Deficit)
 
 
 
 
 
Number of
Shares
 
 
 
 
Amount

$
 
 
$
 
 
$
 
 
$
 
 
$
 
Balance, December 31, 2021
 
 
5,731,000
 
 
 
5,731
 
 
 
17,234
 
 
 
(58
)
 
 
(65,550
)
 
 
(42,643
)
Issuance of Shares for share exchange
 
 
26,350,756
 
 
 
26,351
 
 
 
32,523,344
 
 
 
-
 
 
 
-
 
 
 
32,549,695
 
Issuance of Shares for service
 
 
3,120,000
 
 
 
3,120
 
 
 
(3,120
)
 
 
-
 
 
 
-
 
 
 
-
 
Net (loss) for the year
 
 
-
 
 
 
-
 
 
 
-
 
 
 
-
 
 
 
(1,390,623
)
 
 
(1,390,623
)
Balance, March 31, 2022
 
 
35,201,756
 
 
 
35,202
 
 
 
32,537,458
 
 
 
(58
)
 
 
(1,456,173
)
 
 
31,116,429
 
 
(The accompanying notes are an integral part of these financial statements)
 
4
 
GoLogiq
,Inc.

Statements of Cash Flows

(Expressed in U.S. dollars)
 
 
 
Three months
ended
 
 
 
 
Three months
ended
 
 
 
 
March 31, 2023
 
 
March 31, 2022
 
 
 
$
 
 
$
 
 
 
 
 
 
 
 
OPERATING ACTIVITIES
 
 
 
 
 
 
 
 
Net (Loss) for the Period
 
 
(1,922,213
)
 
 
(1,390,623
)
Changes in Operating Assets and Liabilities:
 
 
 
 
 
 
 
 
Prepaid expense and deposits
 
 
-
 
 
 
(220,801
)
Accounts payable and accrued liabilities
 
 
(90,580
)
 
 
14,000
 
Issuance of shares for service received
 
 
2,354,948
 
 
 
780,000
 
Net Cash (Used in) Operating Activities
 
 
342,155
 
 
 
(817,424
)
FINANCING ACTIVITIES
 
 
 
 
 
 
 
 
Due from related party
 
 
(261,911
)
 
 
547,729
 
Net Cash Provided by (Used in) Financing Activities
 
 
(261,911
)
 
 
547,729
 
INVESTING ACTIVITIES
 
 


 
 

 
Arising from transitional arrangements and carve out assumptions on allocation of CreateApp and GoLogiq costs from Logiq, Inc. to GoLogiq
 
 
-
 
 
 
269,695
 
Net Movement in Investing Activities
 
 
-
 
 
 
269,695
 
Change in Cash
 
 
80,244
 
 
 
-
 
Cash, Beginning of Period
 
 
35,254
 
 
 
-
 
Cash, End of Period
 
 
115,498
 
 
 
-
 
NON-CASH TRANSACTION
 
 
 
 
 
 
 
 
Issuance of shares for services received
 
 
1,807,268
 
 
 
780,000
 
 
(The accompanying notes are an integral part of these financial statements)
 
5
 
GoLogiq, Inc.
Notes to the Financial Statements
For the Three Months Ended March 31, 2023 and 2022
(Expressed in U.S. dollars)
 
Note 1 – Nature of Business and Continuance of Operations
 
GoLogiq, Inc. (formerly known as Lovarra) (the “Company”) was incorporated on January 29, 2018 under the laws of the State of Nevada. As of December 31, 2021, the Company was a shell company focused on software application development, including an expense and income tracker and a physical wallet with a lock that can be opened via Bluetooth linked by a user application. On January 27, 2022, the Company completed the acquisition of the business segment of CreateApp from Logiq Inc. (a fully reporting public company) (“Logiq”). As a result, the Company’s results of operations for the year ended December 31, 2022 include the operations of CreateApp.
 
On May 9, 2022, the Company changed its name from Lovarra Inc. to GoLogiq, with the Secretary of State of the State of California, and on June 9, 2022, the Company’s common stock began trading on the OTC Markets marketplace under the Company’s new name, GoLogiq, Inc., and the new ticker symbol “GOLQ.”
 
On July 27, 2022, Logiq completed the spin off of its direct interests in the Company, in connection with which Logiq distributed an aggregate of 26,350,756 shares of the Company’s common stock then directly owned by Logiq to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of the Company). As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.
 
As of March 31, 2023, Logiq controlled, through one of its subsidiaries, approximately 3.61% of the Company’s outstanding shares of common stock and voting power of the Company’s outstanding securities.
 
As a result of the CreateApp acquisition, the Company ceased to be a shell company (as defined in Rule 12b-2 of the Act), and the Company’s primary business is now that of the CreateApp business. As a result of the CreateApp business acquisition, the Company now offers solutions that help small-to-medium-sized businesses (“SMBs”) to provide access to and reduce transaction friction of e-commerce for their clients globally. The Company’s solutions are provided through its core platform, operated as CreateApp (https://www.createapp.com/), which allows SMBs to establish their point-of-presence on the web.
 
The Company’s CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing CreateApp, which is a platform that is offered as a Platform as a Service (“PaaS”). The Company provides its PaaS to SMBs in a wide variety of industry sectors.
 
Management believes the assumptions underlying the condensed financial statements are reasonable. However, the amounts recorded for the Company’s related party transactions with Logiq and its consolidated subsidiaries may not be considered arm’s length with an unrelated third party. Therefore, the condensed financial statements included herein may not necessarily reflect the results of operations, financial position and cash flows had the Company engaged in such transactions with an unrelated third party during all periods presented. Accordingly, the Company’s historical financial information is not necessarily indicative of what the Company’s results of operations, financial position and cash flows will be in the future, if and when the Company contracts at arm’s length with unrelated third parties for products and services the Company receives from and provides to Logiq.
 
Going Concern
 
These financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to support operations, and the attainment of profitable operations.  During the three months ended March 31, 2023, the Company has incurred operating losses of ($1,922,213) and ($1,390,623)  from operating losses for the three months ended March 31, 2022. As at March 31, 2023, the Company has a working capital deficit of $1,641,538 and an accumulated deficit of ($26,242,085). These factors raise substantial doubt upon the Company’s ability to continue as a going concern. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.
 
6

On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn and increased inflation in the United States. The impact on the Company was significant for the three months ended March 31, 2023 and fiscal 2022, but management continues to monitor the situation as more of the population in the region where we operate is vaccinated and business has begun returning to some normality. In addition, many of our customers are working remotely, which may delay the timing of new business and implementations of our services. If COVID-19 and/or inflation continues to have a substantial impact on our partners, customers, vendors, resellers, or suppliers, our results of operations and overall financial performance could be harmed.
 
Note 2 – Significant Accounting Policies
 
Basis of Presentation
 
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
 
Use of Estimates and Judgments
 
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
 
The Company applies judgment in the application of the going concern assumption which requires management to take into account all available information about the future, which is at least, but not limited to, 12 months from the end of the reporting period.
 
Cash and Cash Equivalents
 
The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.
 
Loss Per Share
 
The Company computes income (loss) per share in accordance with ASC 260 “
Earnings per Share
”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.
 
Note 2 – Significant Accounting Policies
 (continued)
 
Income Taxes
 
The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred income tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred income tax assets to the amount that is believed more likely than not to be realized.

 
7
As of March 31, 2023 and 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions.
 
Fair Value Measurements
 
The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The three-level hierarchy is defined as follows:
 
Level 1 – quoted prices for identical instruments in active markets.
 
Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and
 
Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
 
Financial instruments consist of cash, accounts payable and accrued liabilities, and amounts due to a related party. The recorded values of all financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.
 
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
 
Goodwill and Intangible Assets
 
Goodwill is recorded as the difference between the aggregate consideration in a business combination and the fair value of the acquired net tangible and intangible assets acquired. The Company evaluates goodwill for impairment on an annual basis in the fourth quarter or more frequently if indicators of impairment exist that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Based on that qualitative assessment, if it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company conducts a quantitative goodwill impairment test, which involves comparing the estimated fair value of the reporting unit with its carrying value, including goodwill. The Company estimates the fair value of a reporting unit using a combination of the income and market approach. If the carrying value of the reporting unit exceeds its estimated fair value, an impairment loss is recorded for the difference.
 
Foreign Currency Translation
 
The Company’s functional and reporting currency is the U.S. dollar. Transactions may occur in foreign currencies and management has adopted ASC 830, 
“Foreign Currency Translation Matters”
. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the statement of operations.
 
Comprehensive Loss
 
ASC 220, “
Comprehensive Income
” establishes standards for the reporting and display of comprehensive income and its components in the financial statements. As of March 31, 2023 and 2022, the Company had no items that affected comprehensive loss.

 
8
 
Intangible assets.
 
The Company’s intangible assets consist of its proprietary software platform and technologies namely CreateApp and AtoZ PAY/GO, which is amortized using the straight-line method over five years, commencing April 1, 2022.
 
Recent Accounting Pronouncements
 
In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The Company adopted Topic 842 on January 1, 2019 and there was no material impact on the Company’s financial statements. 
 
The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
 
Note 3 – Related Party Transactions
 
On January 27, 2022, the Logiq completed the transfer of its AppLogiq business to the Company. In connection with the completion of the transfer of AppLogiq to the Company, the Company issued 26,350,756 shares of its common shares to Logiq (the “GoLogiq Shares”). Logiq held the GoLogiq Shares until July 27, 2022, on which date it distributed 100% of the GoLogiq Shares to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of GoLogiq) through a spin off.  As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.
 
On July 26, 2022, the Company sold and issued an aggregate of 2,000,000 shares of its newly created Series A Preferred Stock, par value $0.001 per share (“Series A Preferred”), to certain members of its management for an aggregate purchase price of $20,000 ($0.01 per share). The Series A Preferred Stock issued to each of such members of management are to a repurchase option, and shall vest as follows: (i) 25% at issuance and (ii) the remaining 75% in equal monthly installments over a period of twelve months from the date of issuance, provided that the relevant holder provides continued service to the Company during such period.
 
Note 4 – Business Combination
 
A.
CreateApp

On January 27, 2022, the Company acquired substantially all the CreateApp assets from Logiq in exchange for 26,350,756 shares of the Company’s common stock at a price per share of $1.195411(of par value $0.001). The fair value of the shares of common stock at the close of the transaction was $31,500,000 as determined by a valuation of the business.
 
The acquisition of substantially all the CreateApp assets from Logiq was accounted for as a business combination in accordance with Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), with the results of Lovarra’s historical operations included in the Company’s consolidated financial statements from January 1, 2022. Goodwill has been measured as the excess of the total consideration over the amounts assigned to identifiable assets acquired and liabilities assumed.
 
9
 
On the acquisition date, Lovarra acquired substantially all of the CreateApp assets from Logiq. The fair value of assets acquired assumed were as follows:
 
 
 
$
Intangible assets, net
 
 
24,000,000
Goodwill
 
 
7,500,000
Net assets acquired
 
 
31,500,000
 
Fair valuation methods used for the identifiable net assets acquired in the acquisition make use of quoted prices in active markets, discounted cash flows and risk adjusted weighted cost of capital. The methods used in determining fair value of the intangible assets included consideration of the three traditional approaches to value: market, income, and cost. Accordingly, after due consideration of other appropriate and generally accepted valuation methodologies, the value of intangible assets acquired from Logiq has been developed primarily on the basis of the income approach. Under the income approach, the Company evaluated revenue projections derived from the software technology and the appropriate royalty rate that Lovarra would have paid if Lovarra did not own the software technology.
 
On the acquisition date, goodwill of $7,500,000 and intangible assets of $24,000,000 were recorded. The intangible asset identified during the acquisition is software technology for the CreateApp and Atoz Pay/Go platform, which has a weighted average useful life of five years, which is management’s best estimate at the time of the acquisition.
 
The CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing “CreateApp,” which is a platform that is offered as a PaaS to our customers.
 
AtozPay competes primarily with credit card and debit card service providers, banks with payment processing offerings, other offline payment options and other electronic payment system operators.
 
AtozGo is our PaaS platform that provides mobile payment capabilities for the local food delivery service industry.
 
The Company incurred some accounting and legal fees related to the acquisition of the CreateApp assets. The amount attributable to the Company has been included in general and administrative expenses in the accompanying consolidated statement of operations for the quarter ended March 31, 2023.
 
In the consolidated statements of operations, revenues and expenses include the operations of CreateApp since January 27, 2022, which is the day after the acquisition date.
 
The value of CreateApp platform was revalued to $11,800,000 on February 28, 2023.

Note 5 – Stockholder’s Equity
 
Issuance of Common Stock
 
During the period from January 1, 2023 to March 31, 2023, a total
 of
76,936,479 shares with par value $0.001 per share were issued to various stockholders.
 
Stock-Based Compensation
 
During the three months ended March 31, 2023, a total 7,229,073 shares with par value of $0.001 per share were issued for consultancy services received including shares issued to Directors, Operational Staff, Legal Consultants.


10
 
Note 6 – Subsequent Events
 
 
 
A.
GammaRey
 
 
 
 
 
 
Effective March 7, 2023, the Company, GammaRey and the shareholders of GammaRey (“GammaRey Shareholders”) entered into a share exchange agreement (the “GammaRey Share Exchange Agreement”) and its amendment (the “First Amendment”) which provided for the issuance of an aggregate of 106,666,667 shares of Company common stock in exchange for 100% of the common stock of GammaRey.  At the date of this report, while a material number of shares of GammaRey have been exchanged for Company common stock at the closing, significant and important substantive commercial conditions precedent to the exchange of a material number of the GammaRey shares pursuant to the GammaRey Share Exchange Agreement have not been fully satisfied.  Commensurate with the closing, 2,000,000 shares of the Series A Preferred Stock, par value $0.001 per share (“Series A Preferred”) were converted by the holders into 6,000,000 shares of Company common stock.
 
 
 
GammaRey includes its wholly owned subsidiary,
GenFi Financial Group, Inc. (“GENFI”), which includes its wholly-owned subsidiaries the Nextgen Financial Group Pty Ltd (and subsidiaries thereof) (“Nextgen”) and Ballast Holdings Pty Ltd (and subsidiaries thereof) (“Ballast”) which are both located in Australia (together, the “GENFI Group”) and as defined and described further below, we provide wealth management, direct-to-consumer lending platforms, mortgage broking, accounting, taxation advice, reporting, structuring, and solutions for individual investors and small-to-medium businesses. Through the GENFI Group, we also offer compliance services under its Australian Financial Services License including advice in regard to Managed Investment Schemes (“MIS”), Self-Managed Superannuation Funds (“SMSF”) and other ancillary services.
 
 
 
 
As the Company described in its Original Report, effective March 7, 2023 (the “Closing Date”), the Company, GammaRey and the GammaRey Shareholders effected the legal consummation of the transactions contemplated by the GammaRey Share Exchange Agreement.  On the Closing Date, the Company acquired 100% of the common stock of GammaRey, and the GammaRey Shareholders became entitled to the immediate issuance of an aggregate of seventy-seven million five hundred thousand (77,500,000) shares of common stock of the Company, subject to the satisfaction of post-closing conditions, including provision by all of the GammaRey Shareholders of sufficient personal information to the Company’s transfer agent necessary for the book entry of such shareholders’ shares in GOLQ.  At the date of the Company’s Annual Report on Form 10-K, as filed with the Commission on March 27, 2023, several of the shareholders of GammaRey had not provided sufficient personal information to the Company’s transfer agent necessary for the book entry of all of such shareholders’ share in GOLQ.  Therefore, in an abundance of caution regarding the Company’s outstanding share count as reflected in the Annual Report, the Company reported the number of shares as reflected in its books and records as maintained by its transfer agent, which did not include the shares issuable to the GammaRey Shareholders, and noted the obligations to issue shares to the GammaRey Shareholders in the Annual Report, including in the Subsequent Events sections of the Financial Statements therein.
 
 
 
11
 
 
 
 
 
The aforementioned potential ambiguity in shares outstanding has been resolved and all seventy-seven million five hundred thousand (77,500,000) of such shares were fully issued and recorded in book entry by the Company’s transfer agent on or before April 4, 2023.
 
The GammaRey Shareholders are also entitled to up to an additional twenty-nine million one hundred sixty-six thousand six hundred sixty-six (29,166,667) shares of common stock of the Company being reserved for later issuance to the Shareholders pursuant to the terms of the Share Exchange Agreement.  Such conditions have not been satisfied and therefore, such shares have not been issued as of the date of this report.
 
The shares were exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof, which exempts transactions by an issuer not involving any public offering, and Regulation D and Regulation S under that section, and that these securities, when issued, may not be offered or sold in the United States absent such registration or an applicable exemption from such registration requirements, and will be subject to further contractual restrictions on transfer as described in the Share Exchange Agreement.
 
 
B. 
Nest Egg
 
In addition, on January 30, 2023, the Company entered into a Share Exchange Agreement (the “Nest Egg Share Exchange Agreement”), with Nest Egg Investments LLC, a Delaware limited liability company (“Nest Egg”) and the members of Nest Egg (the “Members”). Pursuant to the Nest Egg Share Exchange Agreement, at the closing thereof (the “Closing”), the Company agreed to exchange the outstanding membership interests of Nest Egg held by the Members for shares of common stock of the Company having a value of $30 million immediately following such exchange.
 
At the date of this report, significant and important substantive commercial conditions precedent to closing on the Nest Egg Share Exchange Agreement have not been fully satisfied. Further information will be provided in an 8-K/A when, and if, conditions precedent to closing have occurred.  As of the date of this report, the transactions contemplated under the Nest Egg Share Exchange Agreement have not closed.
 
 
12


Item 2 – Management’s Discussion and Analysis of Financial Condition and Results of Operations
 
You should read the following discussion and analysis of our financial condition and operating results together with our audited financial statements and related notes included elsewhere in this Report.
 
Unless otherwise indicated, references in this section to the terms “GoLogiq,” the “Company,” “we,” “our” and “us” refer to GoLogiq prior to the CreateApp Acquisition. The term “Legacy CreateApp” refers to the CreateApp business division of Logiq prior to its acquisition by GoLogiq.
 
The financial information included in this Management’s Discussion and Analysis of Financial Condition and Results of Operations is that of GoLogiq prior to the CreateApp Acquisition because the CreateApp Acquisition was consummated after the period covered by the financial statements included in this Report. Accordingly, the historical financial information included in this Report, unless otherwise indicated or as the context otherwise requires, is that of GoLogiq prior to the CreateApp Acquisition.
 
This discussion and analysis contains forward-looking statements based upon current beliefs, plans and expectations that involve risks, uncertainties and assumptions. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Risk Factors” or in other parts of this Report.
 
Introduction and Recent Developments
 
As of December 31, 2021, we were a development stage shell company with minimal operations and no revenues. As of December 31, 2021, we intended to provide subscription-based, highly secure expense and earnings tracking application service for personal and corporate use.
 
On January 27, 2022, we completed the acquisition of the CreateApp business segment from Logiq (a fully reporting public company) (the “CreateApp Acquisition”).
 
On July 27, 2022, Logiq completed the spin off of its direct interests in the Company, in connection with which Logiq distributed an aggregate of 26,350,756 shares of the Company’s common stock then directly owned by Logiq to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of the Company). As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.
 
As of March 31, 2023, Logiq, through one of its subsidiaries, controlled approximately 3.61% of our issued and outstanding shares of common stock and voting power of our outstanding securities.
 
As a result of the CreateApp Acquisition, the Company ceased to be a shell company (as defined in Rule 12b-2 of the Act), and our primary business is now that of the CreateApp business. After the CreateApp Acquisition, we abandoned our previous business model, and now we offer solutions that help small-to-medium-sized businesses (“SMBs”) to provide access to and reduce transaction friction of e-commerce for their clients globally. Our solutions are provided through our core platform, operated as CreateApp (https://www.createapp.com/), which allows SMBs to establish their point-of-presence on the web.
 
Our CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing CreateApp, which is a platform that is offered as a Platform as a Service (“PaaS”). We provide our PaaS to SMBs in a wide variety of industry sectors.
 
Additionally, we acquired our Atoz Pay/Go platform through the CreateApp Acquisition. Our AtozPay platform competes primarily with credit card and debit card service providers, banks with payment processing offerings, other offline payment options and other electronic payment system operators. AtozGo is our PaaS platform that provides mobile payment capabilities for the local food delivery service industry.

 
13
 

Results of Operations
 
Comparison of the three months ended March 31, 2023 and 2022
 
Revenue
 
During the three months ended March 31, 2023, the Company generated $71,916 from its CreateApp platform, compare to $3,309,017 for the three months ended March 31, 2022. Revenues have reduced significantly as a result of strategic shift to targeting end users in FY2023 as compared to wholesale bulk distributors in FY2022.
 
Service revenues
 
During the three months ended March 31, 2023, the Company incurred $38,645 from CreateApp platform operations, compared to $2,235,341 during the three months ended March 31, 2022.
 
Gross margin
 
During the three months ended March 31, 2023, the Company generated gross margin of $33,271 from its CreateApp platform, compared to $1,073,676 during the three months ended March 31, 2022. Our gross margin percentage increased to 46.2% as compared to 32.4% in 2022 Q1.
 
Operating Expenses
 
Operating expenses were $1,955,484 and $2,464,299 for the three months ended March 31, 2023 and 2022, respectively.
 
The increase is mainly due to stock compensation of $1,807,268 and $780,000 for the three months ended March 31, 2023 and 2022, respectively.
Net Loss
 
Our net loss for the three months ended March 31, 2023 was $(1,922,213) compared to net loss of $(1,390,623) during the three months ended March 31, 2022, which increase is mainly attributable to stock compensation of $1,807,268 and compliance costs from the carve out, acquisition and audit of the operations of CreateApp.
 
Liquidity and Capital Resources
 
During the year ended March 31, 2023, our primary sources of capital came from (i) cash flows from our operations, predominantly from providing services under our CreateApp platform, and (ii) our acquisition of the CreateApp working capital balance as of December 31, 2022.
 
As of March 31, 2023, our total assets were $11,915,498, compared to $11,835,254 in total assets as of December 31, 2022.
 
Stockholders’ funds were $10,158,462 as of March 31, 2023, compared to stockholders’ deficit of $9,725,726 as of December 31, 2022.
 
On July 26, 2022, the Company sold and issued an aggregate of 2,000,000 shares of its newly created Series A Preferred stock to certain members of its management for an aggregate purchase price of $20,000 ($0.01 per share).
 
We expect that we will use our future sources of liquidity, cash flows (post-CreateApp Acquisition) and fund raising to fund ongoing operations, research and development projects for new products and technologies, and provide ongoing support services for our customers. Over the next two fiscal years, we anticipate that we will use our liquidity, and cash flows and from our operations together with fund raising to fund our growth. In addition, as part of our business strategy, we may occasionally evaluate potential acquisitions of businesses, products and technologies, and minority equity investments. Accordingly, a portion of our available cash may be used at any time for the acquisition of complementary products or businesses or minority equity investments. Such potential transactions may require substantial capital resources, which may require us to seek additional debt or equity financing. We cannot assure you that we will be able to successfully identify suitable acquisition or investment candidates, complete acquisitions or investments, integrate acquired businesses into our current operations, or expand into new markets. Furthermore, we cannot provide assurances that additional financing will be available to us in any required time frame and on commercially reasonable terms, if at all.

 
14
 

We expect that we will need to raise additional capital through the issuance of additional equity and/or debt. If financing is not available at adequate levels, we may need to revaluate our operating plans. Based on projected activities, management projects that cash and cash equivalents on hand are not sufficient to support operations for at least the next 12 months, which raises substantial doubt about the Company’s ability to continue as a going concern without implementing fund raising or continuing support from its shareholders.
 
Cash Used in Operating Activities
 
Operating activities used $342,155 in operations for the three months ended March 31, 2023, as compared to $(817,424) in for the three months ended March 31, 2022. This increase is attributable to net loss from operations of $(1,922,213).
 
Financing Activities

During the three months ended March 31, 2023, financing activities net cash used in $(261,911) compared to net cash provided $547,729 for the three months ended March 31, 2022
 
Investing Activities
 
Investing activities provided $nil in cash for the three months ended March 31, 2023, as compared to $269,695 for the three months ended March 31, 2022. This decrease is a result of the platform of CreateApp had been completed spin off in Q1 2023.
 
Contractual Obligations and Commitments
 
We had no material contractual obligations as of March 31, 2023.
 
Off-Balance Sheet Financing Arrangements
 
We had no obligations, assets or liabilities, which would be considered off-balance sheet arrangements as of March 31, 2023. We did not participate in transactions that created relationships with unconsolidated entities or financial partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance sheet arrangements. We have not entered into any off-balance sheet financing arrangements, established any special purpose entities, guaranteed any debt or commitments of other entities, or purchased any non-financial assets.
 
Critical Accounting Policies and Significant Judgments and Estimates
 
The preparation of our financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and judgments that affect the amounts reported in those financial statements and accompanying notes. Although we believe that the estimates we use are reasonable, due to the inherent uncertainty involved in making those estimates, actual results reported in future periods could differ from those estimates.
 
Our critical accounting policies and estimates are included in Note of notes to our audited financial statements for the three months ended March 31, 2023, included elsewhere in this Report.
 
Recent Accounting Pronouncements
 
For a description of recent accounting pronouncements, see Note 2 of the notes to our financial statements for the three months ended March 31, 2023, included elsewhere in this Report.
 
Item 3. Quantitative and Qualitative Disclosures about Market Risk.
 
Not applicable.

 
15
 

Item 4. Controls and Procedures
 
Evaluation of Disclosure Controls and Procedures
 
The Company maintains disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended) that are designed to ensure that information required to be disclosed in the Company’s Securities Exchange Act reports is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and that such information is accumulated and communicated to the Company’s management, as appropriate, to allow timely decisions regarding required disclosure.
 
The Company’s management, with the participation of our principal executive and principal financial officer evaluated the effectiveness of the Company’s disclosure controls and procedures as of the end of the period covered by this report. Based upon that evaluation, our principal executive and principal financial officer concluded that, as of the end of the period covered by this report, the Company’s disclosure controls and procedures were not effective.
 
Management Report on Internal Control over Financial Reporting
 
Our management is responsible for establishing and maintaining a system of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) under the Exchange Act) that is designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by an issuer in the reports that it files or submits under the Exchange Act is accumulated and communicated to the issuer’s management, including its principal executive officer or officers and principal financial officer or officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.
 
An evaluation was conducted under the supervision and with the participation of our management of the effectiveness of the design and operation of our disclosure controls and procedures as of March 31, 2023. Based on that evaluation, our management concluded that our disclosure controls and procedures were not effective as of such date to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act, is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms.

 
Inherent Limitations on Effectiveness of Controls
 
Our management, including the CEO and CFO, does not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well-designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of the effectiveness of controls to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.
 
Changes in Internal Control over Financial Reporting
 
Management has determined that, as of March 31, 2023, there were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter then ended that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
 
Our independent registered public accounting firm is not required to, and has not, perform formal testing of our internal controls or policies and has not issued an independent opinion as to the quality of our internal controls.

 
16
 

PART II. OTHER INFORMATION
 
Item 1. Legal Proceedings
 
We are not currently a party to any material legal proceedings. We may, however, in the ordinary course of business face various claims brought by third parties, and we may, from time to time, make claims or take legal actions to assert our rights, including intellectual property rights as well as claims relating to employment matters and the safety or efficacy of our products. Any of these claims could subject us to costly litigation. If this were to happen, the payment of any such awards could have a material adverse effect on our business, financial condition and results of operations. Additionally, any such claims, whether or not successful, could damage our reputation and business.
 
Item 1A. Risk Factors
 
Investing in our common stock involves a high degree of risk. You should carefully consider the risks described below and the risk factors discussed in Part I, “Item 1A. Risk Factors” included in our Annual Report on Form 10-K for the year ended December 31, 2022, filed with the SEC on March 27, 2023 (the “Annual Report”), as well as the other information in this Quarterly Report on Form 10-Q (this “Report”), including our financial statements and the related notes, and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” before deciding whether to invest in our common stock. If any of the risks included in this Quarterly Report and our Annual Report actually occurs, our business, financial condition, results of operations and future prospects could be materially and adversely affected. In such an event, the market price of our common stock could decline, and you may lose all or part of your investment. Additional risks and uncertainties not presently known to us or that we currently deem immaterial also may impair our business operations. Because of the risks discussed in this Quarterly Report and our Annual Report, as well as other variables affecting our operating results, past financial performance should not be considered as a reliable indicator of future performance, and investors should not use historical trends to anticipate results or trends in future periods.
 
There have been no material updates or changes to the risk factors previously disclosed in our Annual Report; provided, however, additional risks not currently known or currently material to us may also harm our business.

 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
 
During the period from January 1, 2023 to March 31, 2023, a total of 76,936,479 shares with par value $0.001 per share were issued to various stockholders.
 
Item 3. Defaults upon Senior Securities
 
No senior securities were issued and outstanding during the three-month period ended March 31, 2023.
 
Item 4. Mine Safety Disclosures
 
Not applicable to our Company.
 
Item 5. Other Information
 
None.

 

17
 

Item 6. Exhibits
 
Exhibit

number
 
Exhibit description
 
Incorporated by Reference (Form Type)
 
Filing Date
 
Filed

herewith
 
 
 
 
 
 
 
 
 
 

   
 

   
     
     
     
     
     
      
      
      
      
101.INS*
 
Inline XBRL Instance Document
 
 
 
 
 
 
101.SCH*
 
Inline XBRL Taxonomy Extension Schema Document
 
 
 
 
 
 
101.CAL*
 
Inline XBRL Taxonomy Extension Calculation Linkbase Document
 
 
 
 
 
 
101.DEF*
 
Inline XBRL Taxonomy Extension Definition Linkbase Document
 
 
 
 
 
 
101.LAB*
 
Inline XBRL Taxonomy Extension Label Linkbase Document
 
 
 
 
 
 
101.PRE*
 
Inline XBRL Taxonomy Extension Presentation Linkbase Document
 
 
 
 
 
 
104*
 
Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101 attachments)
 
 
 
 
 
 
 
18
 

SIGNATURES
 
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
May 22, 2023

 
GoLogiq, Inc.
 
 
 
By:
/s/ Brent Suen
 
 
Brent Suen
 
 
Chairman, President, Chief Executive Officer
(Principal Executive Officer, Principal Financial Officer) 
19
 
EX-31.1 2 gl007_ex31-1.htm EXHIBIT 31.1

 

Exhibit 31.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO EXCHANGE ACT RULE 13a-14(a)/15d-14(a)

AS ADOPTED PURSUANT TO SECTION 302 OF

THE SARBANES-OXLEY ACT OF 2002

 

I,

Brent Suen, certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of GoLogiq, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: May 22, 2023

By:

/s/ Brent Suen

 

 

Brent Suen

 

 

Chairman, President,
Chief Executive Officer

(Principal Executive Officer)

 

EX-31.2 3 gl007_ex31-2.htm EXHIBIT 31.1

 

Exhibit 31.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER PURSUANT TO

RULES 13a-14(a) AND 15d-14(a) UNDER THE SECURITIES EXCHANGE ACT OF 1934,

AS ADOPTED PURSUANT TO SECTION 302 OF
THE SARBANES-OXLEY ACT OF 2002

 

I,

Brent Suen certify that:

 

1.

I have reviewed this Quarterly Report on Form 10-Q of GoLogiq, Inc.;

 

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

(a)

designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)

evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

 

(d)

disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

 

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

(a)

all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

 

(b)

any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

Date: May 22, 2023

By:

/s/ Brent Suen

 

 

Brent Suen

 

 

Chairman, President,
Chief Executive Officer

(Principal Financial Officer)

 

EX-32.1 4 gl007_ex32-1.htm EXHIBIT 32.1

 

Exhibit 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of GoLogiq, Inc. (the “Company”) for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof, the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

(1)

The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

(2)

Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: May 22, 2023

By:

/s/ Brent Suen

 

 

Brent Suen

 

 

Chairman, President,
Chief Executive Officer

(Principal Executive Officer)

 

EX-32.2 5 gl007_ex32-2.htm EXHIBIT 32.2

 

Exhibit 32.2

 

CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO SECTION 906

OF THE SARBANES-OXLEY ACT OF 2002

 

In connection with the Quarterly Report on Form 10-Q of GoLogiq, Inc. (the “Company”) for the quarter ended March 31, 2023, as filed with the Securities and Exchange Commission on the date hereof, the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to his knowledge:

 

(1)

The Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023 (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

 

(2)

Information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

 

Date: May 22, 2023

By:

/s/ Brent Suen

 

 

Brent Suen

 

 

Chairman, President,
Chief Executive Officer

(Principal Financial Officer)

 

EX-101.SCH 6 golq-20230331.xsd XBRL SCHEMA FILE 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Statements of Operations and Comprehensive Loss link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Statements of Stockholder's Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1007 - Disclosure - Nature of Business and Continuance of Operations link:presentationLink link:definitionLink link:calculationLink 1008 - Disclosure - Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Business Combination link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Stockholder's Equity link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Business Combination (Tables) link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Nature of Business and Continuance of Operations (Details) link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Related Party Transactions (Details) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Business Combination (Details) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Business Combination (Details) - Schedule of the fair value of assets acquired assumed link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Stockholder's Equity (Details) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Subsequent Events - Additional information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 golq-20230331_cal.xml XBRL CALCULATION FILE EX-101.DEF 8 golq-20230331_def.xml XBRL DEFINITION FILE EX-101.LAB 9 golq-20230331_lab.xml XBRL LABEL FILE EX-101.PRE 10 golq-20230331_pre.xml XBRL PRESENTATION FILE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.23.1
Cover Page - shares
3 Months Ended
Mar. 31, 2023
May 12, 2023
Document Information [Line Items]    
Entity Registrant Name GoLogiq, Inc.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   129,677,156
Amendment Flag false  
Entity Central Index Key 0001746278  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Mar. 31, 2023  
Document Fiscal Year Focus 2023  
Document Fiscal Period Focus Q1  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Shell Company false  
Entity Ex Transition Period false  
Document Transition Report false  
Entity File Number 333-231286  
Entity Incorporation, State or Country Code NV  
Entity Tax Identification Number 35-2618297  
Entity Address, Address Line One 230 Victoria Street Bugis Junction  
Entity Address, Address Line Two #15-01/08  
Entity Address, City or Town Singapore  
Entity Address, Country SG  
Entity Address, Postal Zip Code 188024  
City Area Code 65  
Local Phone Number 9366 2322  
Entity Interactive Data Current Yes  
Document Quarterly Report true  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheets - USD ($)
Mar. 31, 2023
Dec. 31, 2022
Current Assets    
Cash and cash equivalents $ 115,498 $ 35,254
Intangible assets, net 8,968,000 8,968,000
Goodwill 2,832,000 2,832,000
Total Assets 11,915,498 11,835,254
Current Liabilities    
Accounts payable and accrued liabilities 1,159,651 1,321,483
Due to related parties 597,385 788,045
Total Liabilities 1,757,036 2,109,528
Stockholder's Funds (Deficit)    
Common stock Authorized: 200,000,000 shares of common stock, $0.001 par value 40,444,083 and 5,731,000 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively 124,610 40,444
Preferred stock Authorized: 10,000,000 shares of preferred stock, 2,000,000 shares issued and outstanding as of December 31, 2022 and December 31, 2021 nil, respectively 2,000 2,000
Additional paid-in capital 36,273,995 34,003,212
Share subscriptions receivable (58) (58)
Accumulated deficit (26,242,085) (24,319,872)
Total Stockholder's Funds (Deficit) 10,158,462 9,725,726
TOTAL LIABILITIES AND STOCKHOLDER'S FUNDS $ 11,915,498 $ 11,835,254
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.23.1
Balance Sheets (Parentheticals) - $ / shares
Mar. 31, 2023
Dec. 31, 2022
Statement of Financial Position [Abstract]    
Common stock, shares authorized 200,000,000 200,000,000
Common stock par value (in Dollars per share) $ 0.001 $ 0.001
Common stock, shares issued 124,609,635 40,444,083
Common stock, shares outstanding 124,609,635 40,444,083
Preferred stock, shares authorized 10,000,000 10,000,000
Preferred stock, shares issued 2,000,000 2,000,000
Preferred stock, shares outstanding 2,000,000 2,000,000
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]    
Service Revenue $ 71,916 $ 3,309,017
Cost of Service 38,645 2,235,341
Gross Profit 33,271 1,073,676
Operating Expenses    
General and administrative 1,900,484 1,368,799
Sales and marketing   5,000
Research and development 55,000 1,090,500
Total Operating Expenses 1,955,484 2,464,299
(Loss) from Operations (1,922,213) (1,390,623)
Net (Loss) and Comprehensive (Loss) $ (1,922,213) $ (1,390,623)
Basic and Diluted Net (Loss) per Common Share (in Dollars per share) $ (0.037) $ (0.052)
Weighted Average Number of Common Shares Outstanding (in Shares) 51,477,398 26,637,863
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Stockholder's Equity (Deficit) - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Share Subscriptions Receivable Member
Accumulated Deficit
Balance (in Shares) at Dec. 31, 2021   5,731,000      
Balance at Dec. 31, 2021 $ (42,643) $ 5,731 $ 17,234 $ (58) $ (65,550)
Issuance of Shares for share exchange 32,549,695 $ 26,351 32,523,344    
Issuance of Shares for share exchange (in Shares)   26,350,756      
Issuance of Shares for services   $ 3,120 (3,120)    
Issuance of Shares for services (in Shares)   3,120,000      
Net (loss) for the year (1,390,623)       (1,390,623)
Balance at Mar. 31, 2022 31,116,429 $ 35,202 32,537,458 (58) (1,456,173)
Balance (in Shares) at Mar. 31, 2022   35,201,756      
Balance (in Shares) at Dec. 31, 2022   40,444,083      
Balance at Dec. 31, 2022 9,725,726 $ 42,444 34,003,212 (58) (24,319,872)
Issuance of Shares 2,347,720 $ 76,937 2,270,783    
Issuance of Shares (in Shares)   76,936,479      
Issuance of Shares for services 7,229 $ 7,229      
Issuance of Shares for services (in Shares)   7,229,073      
Net (loss) for the year (1,922,213)       (1,922,213)
Balance at Mar. 31, 2023 $ 10,158,462 $ 126,610 $ 36,273,995 $ (58) $ (26,242,085)
Balance (in Shares) at Mar. 31, 2023   124,609,635      
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.1
Statements of Cash Flows - USD ($)
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
OPERATING ACTIVITIES    
Net (Loss) for the Period $ (1,922,213) $ (1,390,623)
Changes in Operating Assets and Liabilities:    
Prepaid expense and deposits   (220,801)
Accounts payable and accrued liabilities (90,580) 14,000
Issuance of shares for service received 2,354,948 780,000
Net Cash (Used in) Operating Activities 342,155 (817,424)
FINANCING ACTIVITIES    
Due from related party (261,911) 547,729
Net Cash Provided by (Used in) Financing Activities (261,911) 547,729
INVESTING ACTIVITIES    
Arising from transitional arrangements and carve out assumptions on allocation of CreateApp and GoLogiq costs from Logiq, Inc. to GoLogiq   269,695
Net Movement in Investing Activities   269,695
Change in Cash 80,244  
Cash, Beginning of Period 35,254  
Cash, End of Period 115,498  
NON-CASH TRANSACTION    
Issuance of shares for services received $ 1,807,268 $ 780,000
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Business and Continuance of Operations
3 Months Ended
Mar. 31, 2023
Nature of Business and Continuance of Operations [Abstract]  
Nature of Business and Continuance of Operations
Note 1 – Nature of Business and Continuance of Operations
 
GoLogiq, Inc. (formerly known as Lovarra) (the “Company”) was incorporated on January 29, 2018 under the laws of the State of Nevada. As of December 31, 2021, the Company was a shell company focused on software application development, including an expense and income tracker and a physical wallet with a lock that can be opened via Bluetooth linked by a user application. On January 27, 2022, the Company completed the acquisition of the business segment of CreateApp from Logiq Inc. (a fully reporting public company) (“Logiq”). As a result, the Company’s results of operations for the year ended December 31, 2022 include the operations of CreateApp.
 
On May 9, 2022, the Company changed its name from Lovarra Inc. to GoLogiq, with the Secretary of State of the State of California, and on June 9, 2022, the Company’s common stock began trading on the OTC Markets marketplace under the Company’s new name, GoLogiq, Inc., and the new ticker symbol “GOLQ.”
 
On July 27, 2022, Logiq completed the spin off of its direct interests in the Company, in connection with which Logiq distributed an aggregate of 26,350,756 shares of the Company’s common stock then directly owned by Logiq to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of the Company). As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.
 
As of March 31, 2023, Logiq controlled, through one of its subsidiaries, approximately 3.61% of the Company’s outstanding shares of common stock and voting power of the Company’s outstanding securities.
 
As a result of the CreateApp acquisition, the Company ceased to be a shell company (as defined in Rule 12b-2 of the Act), and the Company’s primary business is now that of the CreateApp business. As a result of the CreateApp business acquisition, the Company now offers solutions that help small-to-medium-sized businesses (“SMBs”) to provide access to and reduce transaction friction of e-commerce for their clients globally. The Company’s solutions are provided through its core platform, operated as CreateApp (https://www.createapp.com/), which allows SMBs to establish their point-of-presence on the web.
 
The Company’s CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing CreateApp, which is a platform that is offered as a Platform as a Service (“PaaS”). The Company provides its PaaS to SMBs in a wide variety of industry sectors.
 
Management believes the assumptions underlying the condensed financial statements are reasonable. However, the amounts recorded for the Company’s related party transactions with Logiq and its consolidated subsidiaries may not be considered arm’s length with an unrelated third party. Therefore, the condensed financial statements included herein may not necessarily reflect the results of operations, financial position and cash flows had the Company engaged in such transactions with an unrelated third party during all periods presented. Accordingly, the Company’s historical financial information is not necessarily indicative of what the Company’s results of operations, financial position and cash flows will be in the future, if and when the Company contracts at arm’s length with unrelated third parties for products and services the Company receives from and provides to Logiq.
 
Going Concern
 
These financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to support operations, and the attainment of profitable operations.  During the three months ended March 31, 2023, the Company has incurred operating losses of ($1,922,213) and ($1,390,623)  from operating losses for the three months ended March 31, 2022. As at March 31, 2023, the Company has a working capital deficit of $1,641,538 and an accumulated deficit of ($26,242,085). These factors raise substantial doubt upon the Company’s ability to continue as a going concern. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.
 
On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn and increased inflation in the United States. The impact on the Company was significant for the three months ended March 31, 2023 and fiscal 2022, but management continues to monitor the situation as more of the population in the region where we operate is vaccinated and business has begun returning to some normality. In addition, many of our customers are working remotely, which may delay the timing of new business and implementations of our services. If COVID-19 and/or inflation continues to have a substantial impact on our partners, customers, vendors, resellers, or suppliers, our results of operations and overall financial performance could be harmed.
 
XML 18 R8.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Significant Accounting Policies
Note 2 – Significant Accounting Policies
 
Basis of Presentation
 
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
 
Use of Estimates and Judgments
 
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
 
The Company applies judgment in the application of the going concern assumption which requires management to take into account all available information about the future, which is at least, but not limited to, 12 months from the end of the reporting period.
 
Cash and Cash Equivalents
 
The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.
 
Loss Per Share
 
The Company computes income (loss) per share in accordance with ASC 260 “
Earnings per Share
”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.
 
Income Taxes
 
The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred income tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred income tax assets to the amount that is believed more likely than not to be realized.

As of March 31, 2023 and 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions.
 
Fair Value Measurements
 
The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The three-level hierarchy is defined as follows:
 
Level 1 – quoted prices for identical instruments in active markets.
 
Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and
 
Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
 
Financial instruments consist of cash, accounts payable and accrued liabilities, and amounts due to a related party. The recorded values of all financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.
 
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
 
Goodwill and Intangible Assets
 
Goodwill is recorded as the difference between the aggregate consideration in a business combination and the fair value of the acquired net tangible and intangible assets acquired. The Company evaluates goodwill for impairment on an annual basis in the fourth quarter or more frequently if indicators of impairment exist that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Based on that qualitative assessment, if it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company conducts a quantitative goodwill impairment test, which involves comparing the estimated fair value of the reporting unit with its carrying value, including goodwill. The Company estimates the fair value of a reporting unit using a combination of the income and market approach. If the carrying value of the reporting unit exceeds its estimated fair value, an impairment loss is recorded for the difference.
 
Foreign Currency Translation
 
The Company’s functional and reporting currency is the U.S. dollar. Transactions may occur in foreign currencies and management has adopted ASC 830, 
“Foreign Currency Translation Matters”
. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the statement of operations.
 
Comprehensive Loss
 
ASC 220, “
Comprehensive Income
” establishes standards for the reporting and display of comprehensive income and its components in the financial statements. As of March 31, 2023 and 2022, the Company had no items that affected comprehensive loss.
 
Intangible assets.
 
The Company’s intangible assets consist of its proprietary software platform and technologies namely CreateApp and AtoZ PAY/GO, which is amortized using the straight-line method over five years, commencing April 1, 2022.
 
Recent Accounting Pronouncements
 
In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The Company adopted Topic 842 on January 1, 2019 and there was no material impact on the Company’s financial statements. 
 
The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
XML 19 R9.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions
3 Months Ended
Mar. 31, 2023
Related Party Transactions [Abstract]  
Related Party Transactions
Note 3 – Related Party Transactions
 
On January 27, 2022, the Logiq completed the transfer of its AppLogiq business to the Company. In connection with the completion of the transfer of AppLogiq to the Company, the Company issued 26,350,756 shares of its common shares to Logiq (the “GoLogiq Shares”). Logiq held the GoLogiq Shares until July 27, 2022, on which date it distributed 100% of the GoLogiq Shares to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of GoLogiq) through a spin off.  As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.
 
On July 26, 2022, the Company sold and issued an aggregate of 2,000,000 shares of its newly created Series A Preferred Stock, par value $0.001 per share (“Series A Preferred”), to certain members of its management for an aggregate purchase price of $20,000 ($0.01 per share). The Series A Preferred Stock issued to each of such members of management are to a repurchase option, and shall vest as follows: (i) 25% at issuance and (ii) the remaining 75% in equal monthly installments over a period of twelve months from the date of issuance, provided that the relevant holder provides continued service to the Company during such period.
XML 20 R10.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combination
3 Months Ended
Mar. 31, 2023
Business Combinations [Abstract]  
Business Combination
Note 4 – Business Combination
 
A.
CreateApp

On January 27, 2022, the Company acquired substantially all the CreateApp assets from Logiq in exchange for 26,350,756 shares of the Company’s common stock at a price per share of $1.195411(of par value $0.001). The fair value of the shares of common stock at the close of the transaction was $31,500,000 as determined by a valuation of the business.
 
The acquisition of substantially all the CreateApp assets from Logiq was accounted for as a business combination in accordance with Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), with the results of Lovarra’s historical operations included in the Company’s consolidated financial statements from January 1, 2022. Goodwill has been measured as the excess of the total consideration over the amounts assigned to identifiable assets acquired and liabilities assumed.
 
 
On the acquisition date, Lovarra acquired substantially all of the CreateApp assets from Logiq. The fair value of assets acquired assumed were as follows:
 
 
 
$
Intangible assets, net
 
 
24,000,000
Goodwill
 
 
7,500,000
Net assets acquired
 
 
31,500,000
 
Fair valuation methods used for the identifiable net assets acquired in the acquisition make use of quoted prices in active markets, discounted cash flows and risk adjusted weighted cost of capital. The methods used in determining fair value of the intangible assets included consideration of the three traditional approaches to value: market, income, and cost. Accordingly, after due consideration of other appropriate and generally accepted valuation methodologies, the value of intangible assets acquired from Logiq has been developed primarily on the basis of the income approach. Under the income approach, the Company evaluated revenue projections derived from the software technology and the appropriate royalty rate that Lovarra would have paid if Lovarra did not own the software technology.
 
On the acquisition date, goodwill of $7,500,000 and intangible assets of $24,000,000 were recorded. The intangible asset identified during the acquisition is software technology for the CreateApp and Atoz Pay/Go platform, which has a weighted average useful life of five years, which is management’s best estimate at the time of the acquisition.
 
The CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing “CreateApp,” which is a platform that is offered as a PaaS to our customers.
 
AtozPay competes primarily with credit card and debit card service providers, banks with payment processing offerings, other offline payment options and other electronic payment system operators.
 
AtozGo is our PaaS platform that provides mobile payment capabilities for the local food delivery service industry.
 
The Company incurred some accounting and legal fees related to the acquisition of the CreateApp assets. The amount attributable to the Company has been included in general and administrative expenses in the accompanying consolidated statement of operations for the quarter ended March 31, 2023.
 
In the consolidated statements of operations, revenues and expenses include the operations of CreateApp since January 27, 2022, which is the day after the acquisition date.
 
The value of CreateApp platform was revalued to $11,800,000 on February 28, 2023.
XML 21 R11.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholder's Equity
3 Months Ended
Mar. 31, 2023
Stockholders' Equity Note [Abstract]  
Stockholder's Equity
Note 5 – Stockholder’s Equity
 
Issuance of Common Stock
 
During the period from January 1, 2023 to March 31, 2023, a total
 of
76,936,479 shares with par value $0.001 per share were issued to various stockholders.
 
Stock-Based Compensation
 
During the three months ended March 31, 2023, a total 7,229,073 shares with par value of $0.001 per share were issued for consultancy services received including shares issued to Directors, Operational Staff, Legal Consultants.


XML 22 R12.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events
3 Months Ended
Mar. 31, 2023
Subsequent Events [Abstract]  
Subsequent Events
 
Note 6 – Subsequent Events
 
 
 
A.
GammaRey
 
 
 
 
 
 
Effective March 7, 2023, the Company, GammaRey and the shareholders of GammaRey (“GammaRey Shareholders”) entered into a share exchange agreement (the “GammaRey Share Exchange Agreement”) and its amendment (the “First Amendment”) which provided for the issuance of an aggregate of 106,666,667 shares of Company common stock in exchange for 100% of the common stock of GammaRey.  At the date of this report, while a material number of shares of GammaRey have been exchanged for Company common stock at the closing, significant and important substantive commercial conditions precedent to the exchange of a material number of the GammaRey shares pursuant to the GammaRey Share Exchange Agreement have not been fully satisfied.  Commensurate with the closing, 2,000,000 shares of the Series A Preferred Stock, par value $0.001 per share (“Series A Preferred”) were converted by the holders into 6,000,000 shares of Company common stock.
 
 
 
GammaRey includes its wholly owned subsidiary,
GenFi Financial Group, Inc. (“GENFI”), which includes its wholly-owned subsidiaries the Nextgen Financial Group Pty Ltd (and subsidiaries thereof) (“Nextgen”) and Ballast Holdings Pty Ltd (and subsidiaries thereof) (“Ballast”) which are both located in Australia (together, the “GENFI Group”) and as defined and described further below, we provide wealth management, direct-to-consumer lending platforms, mortgage broking, accounting, taxation advice, reporting, structuring, and solutions for individual investors and small-to-medium businesses. Through the GENFI Group, we also offer compliance services under its Australian Financial Services License including advice in regard to Managed Investment Schemes (“MIS”), Self-Managed Superannuation Funds (“SMSF”) and other ancillary services.
 
 
 
 
As the Company described in its Original Report, effective March 7, 2023 (the “Closing Date”), the Company, GammaRey and the GammaRey Shareholders effected the legal consummation of the transactions contemplated by the GammaRey Share Exchange Agreement.  On the Closing Date, the Company acquired 100% of the common stock of GammaRey, and the GammaRey Shareholders became entitled to the immediate issuance of an aggregate of seventy-seven million five hundred thousand (77,500,000) shares of common stock of the Company, subject to the satisfaction of post-closing conditions, including provision by all of the GammaRey Shareholders of sufficient personal information to the Company’s transfer agent necessary for the book entry of such shareholders’ shares in GOLQ.  At the date of the Company’s Annual Report on Form 10-K, as filed with the Commission on March 27, 2023, several of the shareholders of GammaRey had not provided sufficient personal information to the Company’s transfer agent necessary for the book entry of all of such shareholders’ share in GOLQ.  Therefore, in an abundance of caution regarding the Company’s outstanding share count as reflected in the Annual Report, the Company reported the number of shares as reflected in its books and records as maintained by its transfer agent, which did not include the shares issuable to the GammaRey Shareholders, and noted the obligations to issue shares to the GammaRey Shareholders in the Annual Report, including in the Subsequent Events sections of the Financial Statements therein.
 
 
 
 
 
 
 
 
The aforementioned potential ambiguity in shares outstanding has been resolved and all seventy-seven million five hundred thousand (77,500,000) of such shares were fully issued and recorded in book entry by the Company’s transfer agent on or before April 4, 2023.
 
The GammaRey Shareholders are also entitled to up to an additional twenty-nine million one hundred sixty-six thousand six hundred sixty-six (29,166,667) shares of common stock of the Company being reserved for later issuance to the Shareholders pursuant to the terms of the Share Exchange Agreement.  Such conditions have not been satisfied and therefore, such shares have not been issued as of the date of this report.
 
The shares were exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof, which exempts transactions by an issuer not involving any public offering, and Regulation D and Regulation S under that section, and that these securities, when issued, may not be offered or sold in the United States absent such registration or an applicable exemption from such registration requirements, and will be subject to further contractual restrictions on transfer as described in the Share Exchange Agreement.
 
 
B. 
Nest Egg
 
In addition, on January 30, 2023, the Company entered into a Share Exchange Agreement (the “Nest Egg Share Exchange Agreement”), with Nest Egg Investments LLC, a Delaware limited liability company (“Nest Egg”) and the members of Nest Egg (the “Members”). Pursuant to the Nest Egg Share Exchange Agreement, at the closing thereof (the “Closing”), the Company agreed to exchange the outstanding membership interests of Nest Egg held by the Members for shares of common stock of the Company having a value of $30 million immediately following such exchange.
 
At the date of this report, significant and important substantive commercial conditions precedent to closing on the Nest Egg Share Exchange Agreement have not been fully satisfied. Further information will be provided in an 8-K/A when, and if, conditions precedent to closing have occurred.  As of the date of this report, the transactions contemplated under the Nest Egg Share Exchange Agreement have not closed.
XML 23 R13.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Policies)
3 Months Ended
Mar. 31, 2023
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
 
The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Use of Estimates and Judgments
Use of Estimates and Judgments
 
The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.
 
The Company applies judgment in the application of the going concern assumption which requires management to take into account all available information about the future, which is at least, but not limited to, 12 months from the end of the reporting period.
Cash and Cash Equivalents
Cash and Cash Equivalents
 
The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.
Loss Per Share
Loss Per Share
 
The Company computes income (loss) per share in accordance with ASC 260 “
Earnings per Share
”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.
Income Taxes
Income Taxes
 
The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred income tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred income tax assets to the amount that is believed more likely than not to be realized.

As of March 31, 2023 and 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions.
 
Fair Value Measurements
Fair Value Measurements
 
The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The three-level hierarchy is defined as follows:
 
Level 1 – quoted prices for identical instruments in active markets.
 
Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and
 
Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
 
Financial instruments consist of cash, accounts payable and accrued liabilities, and amounts due to a related party. The recorded values of all financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.
 
Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.
Goodwill and Intangible Assets
Goodwill and Intangible Assets
 
Goodwill is recorded as the difference between the aggregate consideration in a business combination and the fair value of the acquired net tangible and intangible assets acquired. The Company evaluates goodwill for impairment on an annual basis in the fourth quarter or more frequently if indicators of impairment exist that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Based on that qualitative assessment, if it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company conducts a quantitative goodwill impairment test, which involves comparing the estimated fair value of the reporting unit with its carrying value, including goodwill. The Company estimates the fair value of a reporting unit using a combination of the income and market approach. If the carrying value of the reporting unit exceeds its estimated fair value, an impairment loss is recorded for the difference.
Foreign Currency Translation
Foreign Currency Translation
 
The Company’s functional and reporting currency is the U.S. dollar. Transactions may occur in foreign currencies and management has adopted ASC 830, 
“Foreign Currency Translation Matters”
. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the statement of operations.
Comprehensive Loss
Comprehensive Loss
 
ASC 220, “
Comprehensive Income
” establishes standards for the reporting and display of comprehensive income and its components in the financial statements. As of March 31, 2023 and 2022, the Company had no items that affected comprehensive loss.
Intangible assets
Intangible assets.
 
The Company’s intangible assets consist of its proprietary software platform and technologies namely CreateApp and AtoZ PAY/GO, which is amortized using the straight-line method over five years, commencing April 1, 2022.
Recent Accounting Pronouncements
Recent Accounting Pronouncements
 
In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The Company adopted Topic 842 on January 1, 2019 and there was no material impact on the Company’s financial statements. 
 
The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.
XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combination (Tables)
3 Months Ended
Mar. 31, 2023
Business Combinations [Abstract]  
Schedule of the fair value of assets acquired assumed The fair value of assets acquired assumed were as follows:
 
 
 
$
Intangible assets, net
 
 
24,000,000
Goodwill
 
 
7,500,000
Net assets acquired
 
 
31,500,000
XML 25 R15.htm IDEA: XBRL DOCUMENT v3.23.1
Nature of Business and Continuance of Operations (Details) - USD ($)
3 Months Ended
Jul. 27, 2022
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Nature of Business and Continuance of Operations (Details) [Line Items]        
Aggregate shares (in Shares) 26,350,756      
Basis description   1-for-1 basis    
Operating losses   $ (1,922,213) $ (1,390,623)  
Working capital   1,641,538    
Accumulated deficit   $ (26,242,085)   $ (24,319,872)
Business Combination [Member]        
Nature of Business and Continuance of Operations (Details) [Line Items]        
Percentage of common stock and voting power   3.61%    
XML 26 R16.htm IDEA: XBRL DOCUMENT v3.23.1
Significant Accounting Policies (Details)
Apr. 01, 2022
Accounting Policies [Abstract]  
Straight-line method term 5 years
XML 27 R17.htm IDEA: XBRL DOCUMENT v3.23.1
Related Party Transactions (Details) - USD ($)
Jul. 26, 2022
Jan. 27, 2022
Related Party Transactions (Details) [Line Items]    
Share conversion basis   Logiq held the GoLogiq Shares until July 27, 2022, on which date it distributed 100% of the GoLogiq Shares to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis
Issuance of percentage 25.00%  
Remaining issuance of percentage 75.00%  
Series A Preferred Stock [Member]    
Related Party Transactions (Details) [Line Items]    
Issued of aggregate shares (in Shares) 2,000,000  
Preferred stock par value (in Dollars per share) $ 0.001  
Aggregate purchase price $ 20,000  
Aggregate purchase per share (in Dollars per share) $ 0.01  
Logiq Inc [Member]    
Related Party Transactions (Details) [Line Items]    
Common stock issued (in Shares)   26,350,756
XML 28 R18.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combination (Details) - USD ($)
Jan. 27, 2022
Mar. 31, 2023
Feb. 28, 2023
Dec. 31, 2022
Business Combination (Details) [Line Items]        
Common stock per share price (in Dollars per share)   $ 0.001   $ 0.001
Fair value of common stock   $ 124,610   $ 40,444
Create App platform [Member]        
Business Combination (Details) [Line Items]        
Finite lived intangible assets, fair value disclosure     $ 11,800,000  
Business Combination [Member]        
Business Combination (Details) [Line Items]        
Exchanged common stock (in Shares) 26,350,756      
Common stock per share price (in Dollars per share) $ 1.195411      
Common stock, par value (in Dollars per share) $ 0.001      
Fair value of common stock $ 31,500,000      
Goodwill   7,500,000    
Intangible assets   $ 24,000,000    
XML 29 R19.htm IDEA: XBRL DOCUMENT v3.23.1
Business Combination (Details) - Schedule of the fair value of assets acquired assumed
Mar. 31, 2023
USD ($)
Schedule Of The Fair Value Of Assets Acquired Assumed Abstract  
Intangible assets, net $ 24,000,000
Goodwill 7,500,000
Net assets acquired $ 31,500,000
XML 30 R20.htm IDEA: XBRL DOCUMENT v3.23.1
Stockholder's Equity (Details) - $ / shares
3 Months Ended
Mar. 31, 2023
Dec. 31, 2022
Stockholder's Equity [Line Items]    
Stock-based compensation 7,229,073  
Share price $ 0.001  
Common stock par value (in Dollars per share) $ 0.001 $ 0.001
Common Stock [Member]    
Stockholder's Equity [Line Items]    
Issuance of Shares (in Shares) 76,936,479  
Common stock par value (in Dollars per share) $ 0.001  
XML 31 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Subsequent Events - Additional information (Detail) - USD ($)
$ / shares in Units, $ in Millions
Mar. 07, 2023
Mar. 31, 2023
Jan. 30, 2023
Dec. 31, 2022
Subsequent Event [Line Items]        
Common Stock, Capital Shares Reserved for Future Issuance 29,166,667      
Number of shares authorized for issuance 106,666,667      
Percentage of vesting of award 100.00%      
Preferred Stock, Shares Outstanding   2,000,000   2,000,000
Percentage of Common Shares Acquired 100.00%      
Common Stock Shares Issued 77,500,000 124,609,635   40,444,083
Share-Based Payment Award, Shares Issued in Period 77,500,000      
Series A Preferred Stock [Member]        
Subsequent Event [Line Items]        
Preferred Stock, Shares Outstanding 2,000,000      
Preferred Stock, Par or Stated Value Per Share $ 0.001      
Common Stock [Member]        
Subsequent Event [Line Items]        
Stock Issued During Period, Shares, Conversion of Convertible Securities 6,000,000      
Nestegg [Member] | Common Stock [Member]        
Subsequent Event [Line Items]        
Value of equity interests issued or issuable to acquire the entity     $ 30  
XML 32 golq-20230331_htm.xml IDEA: XBRL DOCUMENT 0001746278 2023-03-31 0001746278 2022-12-31 0001746278 2023-01-01 2023-03-31 0001746278 2022-01-01 2022-03-31 0001746278 2022-07-27 2022-07-27 0001746278 2022-04-01 2022-04-01 0001746278 2022-01-27 2022-01-27 0001746278 2022-07-26 2022-07-26 0001746278 2023-05-12 0001746278 2023-03-07 0001746278 2023-03-07 2023-03-07 0001746278 2021-12-31 0001746278 2022-03-31 0001746278 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001746278 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001746278 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001746278 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001746278 golq:BusinessCombinationMember 2023-03-31 0001746278 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2023-03-31 0001746278 us-gaap:CommonStockMember 2023-03-31 0001746278 golq:LogiqIncMember 2022-01-27 0001746278 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-27 0001746278 us-gaap:SeriesAPreferredStockMember 2022-07-26 2022-07-26 0001746278 us-gaap:SeriesAPreferredStockMember 2022-07-26 0001746278 us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember 2022-01-27 2022-01-27 0001746278 golq:CreateAppPlatformMember 2023-02-28 0001746278 us-gaap:CommonStockMember 2023-03-07 2023-03-07 0001746278 us-gaap:SeriesAPreferredStockMember 2023-03-07 0001746278 golq:NesteggMember us-gaap:CommonStockMember 2023-01-30 0001746278 us-gaap:CommonStockMember 2022-12-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001746278 golq:ShareSubscriptionsReceivableMember 2022-12-31 0001746278 us-gaap:RetainedEarningsMember 2022-12-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001746278 golq:ShareSubscriptionsReceivableMember 2023-03-31 0001746278 us-gaap:RetainedEarningsMember 2023-03-31 0001746278 us-gaap:CommonStockMember 2021-12-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001746278 golq:ShareSubscriptionsReceivableMember 2021-12-31 0001746278 us-gaap:RetainedEarningsMember 2021-12-31 0001746278 us-gaap:CommonStockMember 2022-03-31 0001746278 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001746278 golq:ShareSubscriptionsReceivableMember 2022-03-31 0001746278 us-gaap:RetainedEarningsMember 2022-03-31 iso4217:USD shares utr:Year pure iso4217:USD shares --12-31 false 0001746278 Q1 10-Q true 2023-03-31 2023 false 333-231286 GoLogiq, Inc. NV 35-2618297 230 Victoria Street Bugis Junction #15-01/08 Singapore SG 188024 65 9366 2322 Yes Yes Non-accelerated Filer true true false false 129677156 115498 35254 8968000 8968000 2832000 2832000 11915498 11835254 1159651 1321483 597385 788045 1757036 2109528 200000000 200000000 0.001 0.001 124609635 124609635 40444083 40444083 124610 40444 10000000 10000000 2000000 2000000 2000000 2000000 2000 2000 36273995 34003212 58 58 -26242085 -24319872 10158462 9725726 11915498 11835254 71916 3309017 38645 2235341 33271 1073676 1900484 1368799 5000 55000 1090500 1955484 2464299 -1922213 -1390623 -1922213 -1390623 -0.037 -0.052 51477398 26637863 40444083 42444 34003212 -58 -24319872 9725726 76936479 76937 2270783 2347720 7229073 7229 7229 -1922213 -1922213 124609635 126610 36273995 -58 -26242085 10158462 5731000 5731 17234 -58 -65550 -42643 26350756 26351 32523344 32549695 3120000 3120 -3120 -1390623 -1390623 35201756 35202 32537458 -58 -1456173 31116429 -1922213 -1390623 220801 -90580 14000 2354948 780000 342155 -817424 -261911 547729 -261911 547729 269695 269695 80244 35254 115498 1807268 780000 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1 – Nature of Business and Continuance of Operations</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">GoLogiq, Inc. (formerly known as Lovarra) (the “Company”) was incorporated on January 29, 2018 under the laws of the State of Nevada. As of December 31, 2021, the Company was a shell company focused on software application development, including an expense and income tracker and a physical wallet with a lock that can be opened via Bluetooth linked by a user application. On January 27, 2022, the Company completed the acquisition of the business segment of CreateApp from Logiq Inc. (a fully reporting public company) (“Logiq”). As a result, the Company’s results of operations for the year ended December 31, 2022 include the operations of CreateApp.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On May 9, 2022, the Company changed its name from Lovarra Inc. to GoLogiq, with the Secretary of State of the State of California, and on June 9, 2022, the Company’s common stock began trading on the OTC Markets marketplace under the Company’s new name, GoLogiq, Inc., and the new ticker symbol “GOLQ.”</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On July 27, 2022, Logiq completed the spin off of its direct interests in the Company, in connection with which Logiq distributed an aggregate of 26,350,756 shares of the Company’s common stock then directly owned by Logiq to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of the Company). As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2023, Logiq controlled, through one of its subsidiaries, approximately 3.61% of the Company’s outstanding shares of common stock and voting power of the Company’s outstanding securities.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">As a result of the CreateApp acquisition, the Company ceased to be a shell company (as defined in Rule 12b-2 of the Act), and the Company’s primary business is now that of the CreateApp business. As a result of the CreateApp business acquisition, the Company now offers solutions that help small-to-medium-sized businesses (“SMBs”) to provide access to and reduce transaction friction of e-commerce for their clients globally. The Company’s solutions are provided through its core platform, operated as CreateApp (https://www.createapp.com/), which allows SMBs to establish their point-of-presence on the web.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing CreateApp, which is a platform that is offered as a Platform as a Service (“PaaS”). The Company provides its PaaS to SMBs in a wide variety of industry sectors.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Management believes the assumptions underlying the condensed financial statements are reasonable. However, the amounts recorded for the Company’s related party transactions with Logiq and its consolidated subsidiaries may not be considered arm’s length with an unrelated third party. Therefore, the condensed financial statements included herein may not necessarily reflect the results of operations, financial position and cash flows had the Company engaged in such transactions with an unrelated third party during all periods presented. Accordingly, the Company’s historical financial information is not necessarily indicative of what the Company’s results of operations, financial position and cash flows will be in the future, if and when the Company contracts at arm’s length with unrelated third parties for products and services the Company receives from and provides to Logiq.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Going Concern</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">These financial statements have been prepared on the going concern basis, which assumes that the Company will be able to realize its assets and discharge its liabilities in the normal course of business. The continuation of the Company as a going concern is dependent upon the continued financial support from its shareholders, the ability of the Company to obtain necessary equity financing to support operations, and the attainment of profitable operations.  During the three months ended March 31, 2023, the Company has incurred operating losses of ($1,922,213) and ($1,390,623)  from operating losses for the three months ended March 31, 2022. As at March 31, 2023, the Company has a working capital deficit of $1,641,538 and an accumulated deficit of ($26,242,085). These factors raise substantial doubt upon the Company’s ability to continue as a going concern. These financial statements do not reflect any adjustments that may be necessary if the Company is unable to continue as a going concern.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic. This contagious disease outbreak and any related adverse public health developments, has adversely affected workforces, economies, and financial markets globally, leading to an economic downturn and increased inflation in the United States. The impact on the Company was significant for the three months ended March 31, 2023 and fiscal 2022, but management continues to monitor the situation as more of the population in the region where we operate is vaccinated and business has begun returning to some normality. In addition, many of our customers are working remotely, which may delay the timing of new business and implementations of our services. If COVID-19 and/or inflation continues to have a substantial impact on our partners, customers, vendors, resellers, or suppliers, our results of operations and overall financial performance could be harmed.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> 26350756 1-for-1 basis 0.0361 -1922213 -1390623 1641538 -26242085 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 2 – Significant Accounting Policies</div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates and Judgments</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company applies judgment in the application of the going concern assumption which requires management to take into account all available information about the future, which is at least, but not limited to, 12 months from the end of the reporting period.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Loss Per Share</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company computes income (loss) per share in accordance with ASC 260 “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings per Share</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred income tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred income tax assets to the amount that is believed more likely than not to be realized.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2023 and 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The three-level hierarchy is defined as follows:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 1 – quoted prices for identical instruments in active markets.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments consist of cash, accounts payable and accrued liabilities, and amounts due to a related party. The recorded values of all financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Goodwill and Intangible Assets</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space:pre-line; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill is recorded as the difference between the aggregate consideration in a business combination and the fair value of the acquired net tangible and intangible assets acquired. The Company evaluates goodwill for impairment on an annual basis in the fourth quarter or more frequently if indicators of impairment exist that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Based on that qualitative assessment, if it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company conducts a quantitative goodwill impairment test, which involves comparing the estimated fair value of the reporting unit with its carrying value, including goodwill. The Company estimates the fair value of a reporting unit using a combination of the income and market approach. If the carrying value of the reporting unit exceeds its estimated fair value, an impairment loss is recorded for the difference. </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Foreign Currency Translation</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space:pre-line; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s functional and reporting currency is the U.S. dollar. Transactions may occur in foreign currencies and management has adopted ASC 830, </div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">“Foreign Currency Translation Matters”</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the statement of operations.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Comprehensive Loss</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASC 220, “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Comprehensive Income</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">” establishes standards for the reporting and display of comprehensive income and its components in the financial statements. As of March 31, 2023 and 2022, the Company had no items that affected comprehensive loss.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"/><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> </div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Intangible assets.</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s intangible assets consist of its proprietary software platform and technologies namely CreateApp and AtoZ PAY/GO, which is amortized using the straight-line method over five years, commencing April 1, 2022.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space:pre-line; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The Company adopted Topic 842 on January 1, 2019 and there was no material impact on the Company’s financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Basis of Presentation</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates and Judgments</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company regularly evaluates estimates and assumptions related to deferred income tax asset valuation allowances. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities and the accrual of costs and expenses that are not readily apparent from other sources. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company applies judgment in the application of the going concern assumption which requires management to take into account all available information about the future, which is at least, but not limited to, 12 months from the end of the reporting period.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Cash and Cash Equivalents</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all highly liquid investments with maturities of three months or less at the time of purchase to be cash equivalents.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Loss Per Share</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company computes income (loss) per share in accordance with ASC 260 “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Earnings per Share</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">”. Basic loss per share is computed by dividing net income (loss) available to common shareholders by the weighted average number of outstanding common shares during the period. Diluted income (loss) per share gives effect to all dilutive potential common shares outstanding during the period. Dilutive loss per share excludes all potential common shares if their effect is anti-dilutive.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Income Taxes</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company accounts for income taxes using the asset and liability method in accordance with ASC 740, “Income Taxes”. The asset and liability method provides that deferred income tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities, and for operating loss and tax credit carryforwards. Deferred income tax assets and liabilities are measured using the currently enacted tax rates and laws that will be in effect when the differences are expected to reverse. The Company records a valuation allowance to reduce deferred income tax assets to the amount that is believed more likely than not to be realized.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><br/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">As of March 31, 2023 and 2022, the Company did not have any amounts recorded pertaining to uncertain tax positions.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Fair Value Measurements</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company measures and discloses the estimated fair value of financial assets and liabilities using the fair value hierarchy prescribed by U.S. generally accepted accounting principles. The fair value hierarchy has three levels, which are based on reliable available inputs of observable data. The hierarchy requires the use of observable market data when available. The three-level hierarchy is defined as follows:</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 1 – quoted prices for identical instruments in active markets.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 2 – quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model derived valuations in which significant inputs and significant value drivers are observable in active markets; and</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Level 3 – fair value measurements derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments consist of cash, accounts payable and accrued liabilities, and amounts due to a related party. The recorded values of all financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations.</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Fair value estimates are made at a specific point in time, based on relevant market information and information about the financial instrument. These estimates are subjective in nature and involve uncertainties and matters of significant judgment and therefore cannot be determined with precision. Changes in assumptions could significantly affect the estimates.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Goodwill and Intangible Assets</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space:pre-line; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Goodwill is recorded as the difference between the aggregate consideration in a business combination and the fair value of the acquired net tangible and intangible assets acquired. The Company evaluates goodwill for impairment on an annual basis in the fourth quarter or more frequently if indicators of impairment exist that would more likely than not reduce the fair value of a reporting unit below its carrying amount. The Company first assesses qualitative factors to determine whether it is more likely than not that the fair value of a reporting unit is less than its carrying value. Based on that qualitative assessment, if it is more likely than not that the fair value of a reporting unit is less than its carrying value, the Company conducts a quantitative goodwill impairment test, which involves comparing the estimated fair value of the reporting unit with its carrying value, including goodwill. The Company estimates the fair value of a reporting unit using a combination of the income and market approach. If the carrying value of the reporting unit exceeds its estimated fair value, an impairment loss is recorded for the difference. </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Foreign Currency Translation</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space:pre-line; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s functional and reporting currency is the U.S. dollar. Transactions may occur in foreign currencies and management has adopted ASC 830, </div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">“Foreign Currency Translation Matters”</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">. Monetary assets and liabilities denominated in foreign currencies are translated using the exchange rate prevailing at the balance sheet date. Non-monetary assets and liabilities denominated in foreign currencies are translated at rates of exchange in effect at the date of the transaction. Average monthly rates are used to translate revenues and expenses. Gains and losses arising on translation or settlement of foreign currency denominated transactions or balances are included in the statement of operations.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Comprehensive Loss</div></div></div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASC 220, “</div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Comprehensive Income</div></div><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">” establishes standards for the reporting and display of comprehensive income and its components in the financial statements. As of March 31, 2023 and 2022, the Company had no items that affected comprehensive loss.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Intangible assets.</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company’s intangible assets consist of its proprietary software platform and technologies namely CreateApp and AtoZ PAY/GO, which is amortized using the straight-line method over five years, commencing April 1, 2022.</div></div> P5Y <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="text-decoration:underline;display:inline;"><div style="font-style:italic;display:inline;">Recent Accounting Pronouncements</div></div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space:pre-line; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In February 2016, Topic 842, Leases was issued to replace the leases requirements in Topic 840, Leases. The main difference between previous GAAP and Topic 842 is the recognition of lease assets and lease liabilities by lessees for those leases classified as operating leases under previous GAAP. A lessee should recognize in the balance sheet a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term. For leases with a term of 12 months or less, a lessee is permitted to make an accounting policy election by class of underlying asset not to recognize lease assets and lease liabilities. If a lessee makes this election, it should recognize lease expense for such leases generally on a straight-line basis over the lease term. The accounting applied by a lessor is largely unchanged from that applied under previous GAAP. The Company adopted Topic 842 on January 1, 2019 and there was no material impact on the Company’s financial statements. </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 3 – Related Party Transactions</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On January 27, 2022, the Logiq completed the transfer of its AppLogiq business to the Company. In connection with the completion of the transfer of AppLogiq to the Company, the Company issued 26,350,756 shares of its common shares to Logiq (the “GoLogiq Shares”). Logiq held the GoLogiq Shares until July 27, 2022, on which date it distributed 100% of the GoLogiq Shares to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis (i.e. for every 1 share of Logiq held on December 30, 2021, the holder thereof received 1 share of GoLogiq) through a spin off.  As a result of the completion of the spin off, as of July 27, 2022, the Company is no longer a majority owned subsidiary of Logiq.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">On July 26, 2022, the Company sold and issued an aggregate of 2,000,000 shares of its newly created Series A Preferred Stock, par value $0.001 per share (“Series A Preferred”), to certain members of its management for an aggregate purchase price of $20,000 ($0.01 per share). The Series A Preferred Stock issued to each of such members of management are to a repurchase option, and shall vest as follows: (i) 25% at issuance and (ii) the remaining 75% in equal monthly installments over a period of twelve months from the date of issuance, provided that the relevant holder provides continued service to the Company during such period.</div></div> 26350756 Logiq held the GoLogiq Shares until July 27, 2022, on which date it distributed 100% of the GoLogiq Shares to Logiq’s stockholders of record as of December 30, 2021 on a 1-for-1 basis 2000000 0.001 20000 0.01 0.25 0.75 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 4 – Business Combination</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="margin-top: 1em; margin-bottom: 1em"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div> <table cellpadding="0" cellspacing="0" style="width:100%; font-family:'Times New Roman'; font-size:12pt; border-spacing:0px; border-collapse:collapse;text-indent: 0px;"> <tr style="vertical-align:top"> <td style="width:0in; overflow-wrap:break-word; vertical-align:top"/> <td style="width: 0.25in; font-size: 10pt; line-height: 12pt;"> <div style="font-size: 10pt; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt;"><div style="display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">A.</div></div><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div></div></div> </td> <td style="font-size: 10pt; line-height: 12pt;"> <div style="font-size: 10pt; margin-top: 0px; margin-right: 0px; margin-bottom: 0px; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt;"><div style="display:inline;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">CreateApp</div></div></div></div> </td> </tr> </table> <div style="clear:both;max-height:0pt;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On January 27, 2022, the Company acquired substantially all the CreateApp assets from Logiq in exchange for 26,350,756 shares of the Company’s common stock at a price per share of $1.195411(of par value $0.001). The fair value of the shares of common stock at the close of the transaction was $31,500,000 as determined by a valuation of the business.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The acquisition of substantially all the CreateApp assets from Logiq was accounted for as a business combination in accordance with Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), with the results of Lovarra’s historical operations included in the Company’s consolidated financial statements from January 1, 2022. Goodwill has been measured as the excess of the total consideration over the amounts assigned to identifiable assets acquired and liabilities assumed.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> </div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On the acquisition date, Lovarra acquired substantially all of the CreateApp assets from Logiq. The fair value of assets acquired assumed were as follows:</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="null;text-indent: 0px;;text-align:left;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;;margin-right : auto;"> <tr> <td style="width: 88%; padding: 0px 0in 0.5px; font-size: 10pt; vertical-align: bottom;"> <div style="margin-top: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; line-height: 12pt; text-align: center;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in 0in 0.5px; font-size: 10pt; vertical-align: bottom;"> <div style="margin-top: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; line-height: 12pt; text-align: center;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td colspan="2" style="padding: 0in; font-size: 10pt; white-space: nowrap; vertical-align: bottom; border-bottom: 1px solid black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt; text-align: center; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> </tr> <tr> <td style="width: 88%; padding: 0px 0in; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets, net</div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">24,000,000</div></div> </td> </tr> <tr> <td style="width: 88%; padding: 0px 0in 0.375pt; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Goodwill</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.375pt; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom; border-bottom: 0.75pt solid black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom; border-bottom: 0.75pt solid black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">7,500,000</div></div> </td> </tr> <tr> <td style="width: 88%; padding: 0px 0in 1.25pt; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Net assets acquired</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom; border-bottom: 2.5pt double black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom; border-bottom: 2.5pt double black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">31,500,000</div></div> </td> </tr> </table> <div style="clear: both; max-height: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> <div style="clear: both; max-height: 0px; text-indent: 0px;"/> </div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"> </div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Fair valuation methods used for the identifiable net assets acquired in the acquisition make use of quoted prices in active markets, discounted cash flows and risk adjusted weighted cost of capital. The methods used in determining fair value of the intangible assets included consideration of the three traditional approaches to value: market, income, and cost. Accordingly, after due consideration of other appropriate and generally accepted valuation methodologies, the value of intangible assets acquired from Logiq has been developed primarily on the basis of the income approach. Under the income approach, the Company evaluated revenue projections derived from the software technology and the appropriate royalty rate that Lovarra would have paid if Lovarra did not own the software technology.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">On the acquisition date, goodwill of $7,500,000 and intangible assets of $24,000,000 were recorded. The intangible asset identified during the acquisition is software technology for the CreateApp and Atoz Pay/Go platform, which has a weighted average useful life of five years, which is management’s best estimate at the time of the acquisition.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The CreateApp platform enables SMBs to create a mobile app for their business without the need of technical knowledge, high investment, or background in IT by utilizing “CreateApp,” which is a platform that is offered as a PaaS to our customers.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">AtozPay competes primarily with credit card and debit card service providers, banks with payment processing offerings, other offline payment options and other electronic payment system operators.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">AtozGo is our PaaS platform that provides mobile payment capabilities for the local food delivery service industry.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="background: none; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The Company incurred some accounting and legal fees related to the acquisition of the CreateApp assets. The amount attributable to the Company has been included in general and administrative expenses in the accompanying consolidated statement of operations for the quarter ended March 31, 2023.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">In the consolidated statements of operations, revenues and expenses include the operations of CreateApp since January 27, 2022, which is the day after the acquisition date.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The value of CreateApp platform was revalued to $11,800,000 on February 28, 2023.</div></div> 26350756 1.195411 0.001 31500000 The fair value of assets acquired assumed were as follows:<div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; border-spacing: 0px;;text-indent: 0px;;margin-right : auto;"> <tr> <td style="width: 88%; padding: 0px 0in 0.5px; font-size: 10pt; vertical-align: bottom;"> <div style="margin-top: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; line-height: 12pt; text-align: center;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td style="padding: 0in 0in 0.5px; font-size: 10pt; vertical-align: bottom;"> <div style="margin-top: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; line-height: 12pt; text-align: center;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div> </td> <td colspan="2" style="padding: 0in; font-size: 10pt; white-space: nowrap; vertical-align: bottom; border-bottom: 1px solid black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt; text-align: center; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">$</div></div> </td> </tr> <tr> <td style="width: 88%; padding: 0px 0in; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Intangible assets, net</div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">24,000,000</div></div> </td> </tr> <tr> <td style="width: 88%; padding: 0px 0in 0.375pt; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Goodwill</div></div> </td> <td style="width: 1%; padding: 0in 0in 0.375pt; font-size: 10pt; background-color: rgba(255, 255, 255, 0); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgba(255, 255, 255, 0); text-align: left; vertical-align: bottom; border-bottom: 0.75pt solid black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgba(255, 255, 255, 0); text-align: right; vertical-align: bottom; border-bottom: 0.75pt solid black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">7,500,000</div></div> </td> </tr> <tr> <td style="width: 88%; padding: 0px 0in 1.25pt; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0px; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">Net assets acquired</div></div> </td> <td style="width: 1%; padding: 0in 0in 1.25pt; font-size: 10pt; background-color: rgb(204, 238, 255); vertical-align: bottom;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 1%; padding: 0in; font-size: 10pt; background-color: rgb(204, 238, 255); text-align: left; vertical-align: bottom; border-bottom: 2.5pt double black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; margin-left: 0in; text-indent: 0in; text-align: left; white-space: nowrap;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> </td> <td style="width: 10%; padding: 0in; font-size: 10pt; white-space: nowrap; background-color: rgb(204, 238, 255); text-align: right; vertical-align: bottom; border-bottom: 2.5pt double black;"> <div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; font-size: 10pt; margin-right: 0in; line-height: 12pt; white-space: nowrap; text-align: right;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, Times, &quot;serif&quot;; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px; white-space: nowrap;;display:inline;">31,500,000</div></div> </td> </tr> </table> 24000000 7500000 31500000 7500000 24000000 11800000 <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 5 – Stockholder’s Equity</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Issuance of Common Stock</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the period from January 1, 2023 to March 31, 2023, a total<div style="display:inline;"> of</div> 76,936,479 shares with par value $0.001 per share were issued to various stockholders.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Stock-Based Compensation</div></div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">During the three months ended March 31, 2023, a total 7,229,073 shares with par value of $0.001 per share were issued for consultancy services received including shares issued to Directors, Operational Staff, Legal Consultants.</div></div> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"/> <div style="font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; margin-bottom: 0px; margin-top: 0px; text-align: justify; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><br/></div> <div style="margin-top: 1em; margin-bottom: 1em"><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/></div> <div style="margin: 0px 0px 0px 0.7pt; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;"><div style="text-indent: 0px; letter-spacing: 0px; top: 0px; background: none;;display:inline;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;"/></div></div><div style="white-space: pre-wrap; font-family: &quot;Times New Roman&quot;, &quot;serif&quot;; font-size: 10pt; line-height: 12pt; background-image: none; background-position: initial; background-size: initial; background-repeat: initial; background-attachment: initial; background-origin: initial; background-clip: initial; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"/><br/></div> 76936479 0.001 7229073 0.001 <div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin: 0px 0px 0px 0.7pt; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-weight:bold;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;text-indent: 0px;;display:inline;">Note 6 – Subsequent Events</div></div></div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 0px; margin-bottom: 0px;;text-indent: 0px;"/><div style="margin-top: 1em; margin-bottom: 1em"> </div><table cellpadding="0" cellspacing="0" style="width:100%; font-family:'Times New Roman'; font-size:12pt; border-spacing:0px; border-collapse:collapse;text-indent: 0px;"><tr style="vertical-align:top"><td style="width: 0in; overflow-wrap: break-word; vertical-align: top; font-family: &quot;Times New Roman&quot;, serif;"> </td><td style="width: 0.25in; font-size: 10pt; line-height: 12pt;"><div style="font-size: 10pt; margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">A.</div></div></div></td><td><div style="font-size: 10pt; margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt;"><div style="font-style:italic;display:inline;"><div style="color: rgb(0, 0, 0); background: none; letter-spacing: 0px; top: 0px;;display:inline;">GammaRey</div></div></div></td></tr></table><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="text-align: justify; margin: 0px 0px 0px 0in; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Effective March 7, 2023, the Company, GammaRey and the shareholders of GammaRey (“GammaRey Shareholders”) entered into a share exchange agreement (the “GammaRey Share Exchange Agreement”) and its amendment (the “First Amendment”) which provided for the issuance of an aggregate of 106,666,667 shares of Company common stock in exchange for 100% of the common stock of GammaRey.  At the date of this report, while a material number of shares of GammaRey have been exchanged for Company common stock at the closing, significant and important substantive commercial conditions precedent to the exchange of a material number of the GammaRey shares pursuant to the GammaRey Share Exchange Agreement have not been fully satisfied.  Commensurate with the closing, 2,000,000 shares of the Series A Preferred Stock, par value $0.001 per share (“Series A Preferred”) were converted by the holders into 6,000,000 shares of Company common stock.</div></div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">GammaRey includes its wholly owned subsidiary, </div><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">GenFi Financial Group, Inc. (“GENFI”), which includes its wholly-owned subsidiaries the Nextgen Financial Group Pty Ltd (and subsidiaries thereof) (“Nextgen”) and Ballast Holdings Pty Ltd (and subsidiaries thereof) (“Ballast”) which are both located in Australia (together, the “GENFI Group”) and as defined and described further below, we provide wealth management, direct-to-consumer lending platforms, mortgage broking, accounting, taxation advice, reporting, structuring, and solutions for individual investors and small-to-medium businesses. Through the GENFI Group, we also offer compliance services under its Australian Financial Services License including advice in regard to Managed Investment Schemes (“MIS”), Self-Managed Superannuation Funds (“SMSF”) and other ancillary services.</div></div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 1em; margin-bottom: 1em"/><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">As the Company described in its Original Report, effective March 7, 2023 (the “Closing Date”), the Company, GammaRey and the GammaRey Shareholders effected the legal consummation of the transactions contemplated by the GammaRey Share Exchange Agreement.  On the Closing Date, the Company acquired 100% of the common stock of GammaRey, and the GammaRey Shareholders became entitled to the immediate issuance of an aggregate of seventy-seven million five hundred thousand (77,500,000) shares of common stock of the Company, subject to the satisfaction of post-closing conditions, including provision by all of the GammaRey Shareholders of sufficient personal information to the Company’s transfer agent necessary for the book entry of such shareholders’ shares in GOLQ.  At the date of the Company’s Annual Report on Form 10-K, as filed with the Commission on March 27, 2023, several of the shareholders of GammaRey had not provided sufficient personal information to the Company’s transfer agent necessary for the book entry of all of such shareholders’ share in GOLQ.  Therefore, in an abundance of caution regarding the Company’s outstanding share count as reflected in the Annual Report, the Company reported the number of shares as reflected in its books and records as maintained by its transfer agent, which did not include the shares issuable to the GammaRey Shareholders, and noted the obligations to issue shares to the GammaRey Shareholders in the Annual Report, including in the Subsequent Events sections of the Financial Statements therein.</div></div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"/><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin: 0px 0px 0px 0in; text-align: justify; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"> </div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div style="margin-top: 1em; margin-bottom: 1em"> </div><div> </div><div> </div><div style="margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The aforementioned potential ambiguity in shares outstanding has been resolved and all seventy-seven million five hundred thousand (77,500,000) of such shares were fully issued and recorded in book entry by the Company’s transfer agent on or before April 4, 2023.</div></div><div style="text-align: justify; margin-top: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><div style="text-align: justify; margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The GammaRey Shareholders are also entitled to up to an additional twenty-nine million one hundred sixty-six thousand six hundred sixty-six (29,166,667) shares of common stock of the Company being reserved for later issuance to the Shareholders pursuant to the terms of the Share Exchange Agreement.  Such conditions have not been satisfied and therefore, such shares have not been issued as of the date of this report.</div></div><div style="text-align: justify; margin-top: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><div style="text-align: justify; margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">The shares were exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2) thereof, which exempts transactions by an issuer not involving any public offering, and Regulation D and Regulation S under that section, and that these securities, when issued, may not be offered or sold in the United States absent such registration or an applicable exemption from such registration requirements, and will be subject to further contractual restrictions on transfer as described in the Share Exchange Agreement.</div></div><div style="text-align: justify; margin-top: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><table cellpadding="0" cellspacing="0" style="width:100%; font-family:'Times New Roman'; font-size:10pt; border-spacing:0px; border-collapse:collapse;text-indent: 0px;"><tr style="vertical-align:top"><td style="width: 0in; overflow-wrap: break-word; vertical-align: top; font-family: &quot;Times New Roman&quot;, serif; font-size: 0px;"> </td><td style="width: 0.25in; vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: 12pt;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">B. </div></div></div></td><td style="vertical-align: top; overflow-wrap: break-word; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt;"><div style="font-family: &quot;Times New Roman&quot;, serif; margin-right: 0px; margin-bottom: 0px; margin-top: 0px; line-height: normal;"><div style="font-style:italic;display:inline;"><div style="font-size: 10pt; color: rgb(0, 0, 0); line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">Nest Egg</div></div></div></td></tr></table><div style="clear:both;max-height:0pt;;text-indent: 0px;"/><div style="margin: 0px 0px 0px 0.7pt; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><div style="text-align: justify; margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">In addition, on January 30, 2023, the Company entered into a Share Exchange Agreement (the “Nest Egg Share Exchange Agreement”), with Nest Egg Investments LLC, a Delaware limited liability company (“Nest Egg”) and the members of Nest Egg (the “Members”). Pursuant to the Nest Egg Share Exchange Agreement, at the closing thereof (the “Closing”), the Company agreed to exchange the outstanding membership interests of Nest Egg held by the Members for shares of common stock of the Company having a value of $30 million immediately following such exchange.</div></div><div style="text-align: justify; margin-top: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; margin-bottom: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; white-space: pre-wrap; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;;white-space:pre-wrap;"> </div></div><div style="text-align: justify; margin-top: 0px; margin-bottom: 0px; font-family: &quot;Times New Roman&quot;, serif; font-size: 10pt; margin-right: 0px; line-height: 12pt; background: none;;text-indent: 0px;"><div style="font-size: 10pt; color: rgb(0, 0, 0); font-family: &quot;Times New Roman&quot;, serif; line-height: 12pt; background: none; letter-spacing: 0px; top: 0px;;display:inline;">At the date of this report, significant and important substantive commercial conditions precedent to closing on the Nest Egg Share Exchange Agreement have not been fully satisfied. Further information will be provided in an 8-K/A when, and if, conditions precedent to closing have occurred.  As of the date of this report, the transactions contemplated under the Nest Egg Share Exchange Agreement have not closed.</div></div> 106666667 1 2000000 0.001 6000000 1 77500000 77500000 29166667 30000000 EXCEL 33 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 34 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 35 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 36 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.1 html 46 127 1 false 11 0 false 5 false false R1.htm 1001 - Document - Cover Page Sheet http://www.gologiq.com/role/CoverPage Cover Page Cover 1 false false R2.htm 1002 - Statement - Balance Sheets Sheet http://www.gologiq.com/role/BalanceSheets Balance Sheets Statements 2 false false R3.htm 1003 - Statement - Balance Sheets (Parentheticals) Sheet http://www.gologiq.com/role/BalanceSheetsParentheticals Balance Sheets (Parentheticals) Statements 3 false false R4.htm 1004 - Statement - Statements of Operations and Comprehensive Loss Sheet http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss Statements of Operations and Comprehensive Loss Statements 4 false false R5.htm 1005 - Statement - Statements of Stockholder's Equity (Deficit) Sheet http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit Statements of Stockholder's Equity (Deficit) Statements 5 false false R6.htm 1006 - Statement - Statements of Cash Flows Sheet http://www.gologiq.com/role/StatementsOfCashFlows Statements of Cash Flows Statements 6 false false R7.htm 1007 - Disclosure - Nature of Business and Continuance of Operations Sheet http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperations Nature of Business and Continuance of Operations Notes 7 false false R8.htm 1008 - Disclosure - Significant Accounting Policies Sheet http://www.gologiq.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 8 false false R9.htm 1009 - Disclosure - Related Party Transactions Sheet http://www.gologiq.com/role/RelatedPartyTransactions Related Party Transactions Notes 9 false false R10.htm 1010 - Disclosure - Business Combination Sheet http://www.gologiq.com/role/BusinessCombination Business Combination Notes 10 false false R11.htm 1011 - Disclosure - Stockholder's Equity Sheet http://www.gologiq.com/role/StockholdersEquity Stockholder's Equity Notes 11 false false R12.htm 1012 - Disclosure - Subsequent Events Sheet http://www.gologiq.com/role/SubsequentEvents Subsequent Events Notes 12 false false R13.htm 1013 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.gologiq.com/role/SignificantAccountingPolicies 13 false false R14.htm 1014 - Disclosure - Business Combination (Tables) Sheet http://www.gologiq.com/role/BusinessCombinationTables Business Combination (Tables) Tables http://www.gologiq.com/role/BusinessCombination 14 false false R15.htm 1015 - Disclosure - Nature of Business and Continuance of Operations (Details) Sheet http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails Nature of Business and Continuance of Operations (Details) Details http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperations 15 false false R16.htm 1016 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.gologiq.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies 16 false false R17.htm 1017 - Disclosure - Related Party Transactions (Details) Sheet http://www.gologiq.com/role/RelatedPartyTransactionsDetails Related Party Transactions (Details) Details http://www.gologiq.com/role/RelatedPartyTransactions 17 false false R18.htm 1018 - Disclosure - Business Combination (Details) Sheet http://www.gologiq.com/role/BusinessCombinationDetails Business Combination (Details) Details http://www.gologiq.com/role/BusinessCombinationTables 18 false false R19.htm 1019 - Disclosure - Business Combination (Details) - Schedule of the fair value of assets acquired assumed Sheet http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed Business Combination (Details) - Schedule of the fair value of assets acquired assumed Details http://www.gologiq.com/role/BusinessCombinationTables 19 false false R20.htm 1020 - Disclosure - Stockholder's Equity (Details) Sheet http://www.gologiq.com/role/StockholdersEquityDetails Stockholder's Equity (Details) Details http://www.gologiq.com/role/StockholdersEquity 20 false false R21.htm 1021 - Disclosure - Subsequent Events - Additional information (Detail) Sheet http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail Subsequent Events - Additional information (Detail) Details 21 false false All Reports Book All Reports [dq-0542-Deprecated-Concept] Concept DueToOtherRelatedPartiesNoncurrent in us-gaap/2022 used in 2 facts was deprecated in us-gaap/2023 as of 2023 and should not be used. golq-20230331.htm 461 golq-20230331.htm gl007_ex31-1.htm gl007_ex31-2.htm gl007_ex32-1.htm gl007_ex32-2.htm golq-20230331.xsd golq-20230331_cal.xml golq-20230331_def.xml golq-20230331_lab.xml golq-20230331_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 39 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "golq-20230331.htm": { "axisCustom": 0, "axisStandard": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2022": 176, "http://xbrl.sec.gov/dei/2022": 28 }, "contextCount": 46, "dts": { "calculationLink": { "local": [ "golq-20230331_cal.xml" ] }, "definitionLink": { "local": [ "golq-20230331_def.xml" ] }, "inline": { "local": [ "golq-20230331.htm" ] }, "labelLink": { "local": [ "golq-20230331_lab.xml" ] }, "presentationLink": { "local": [ "golq-20230331_pre.xml" ] }, "schema": { "local": [ "golq-20230331.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/currency/2022/currency-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/exch/2022/exch-2022.xsd", "https://xbrl.sec.gov/naics/2022/naics-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd", "https://xbrl.sec.gov/stpr/2022/stpr-2022.xsd" ] } }, "elementCount": 192, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2022": 4, "total": 4 }, "keyCustom": 6, "keyStandard": 121, "memberCustom": 5, "memberStandard": 5, "nsprefix": "golq", "nsuri": "http://www.gologiq.com/20230331", "report": { "R1": { "firstAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "1001 - Document - Cover Page", "menuCat": "Cover", "order": "1", "role": "http://www.gologiq.com/role/CoverPage", "shortName": "Cover Page", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1010 - Disclosure - Business Combination", "menuCat": "Notes", "order": "10", "role": "http://www.gologiq.com/role/BusinessCombination", "shortName": "Business Combination", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1011 - Disclosure - Stockholder's Equity", "menuCat": "Notes", "order": "11", "role": "http://www.gologiq.com/role/StockholdersEquity", "shortName": "Stockholder's Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1012 - Disclosure - Subsequent Events", "menuCat": "Notes", "order": "12", "role": "http://www.gologiq.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1013 - Disclosure - Significant Accounting Policies (Policies)", "menuCat": "Policies", "order": "13", "role": "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies", "shortName": "Significant Accounting Policies (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:SignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1014 - Disclosure - Business Combination (Tables)", "menuCat": "Tables", "order": "14", "role": "http://www.gologiq.com/role/BusinessCombinationTables", "shortName": "Business Combination (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P07_27_2022To07_27_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesOther", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1015 - Disclosure - Nature of Business and Continuance of Operations (Details)", "menuCat": "Details", "order": "15", "role": "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails", "shortName": "Nature of Business and Continuance of Operations (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:NatureOfOperations", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P07_27_2022To07_27_2022", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesOther", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1016 - Disclosure - Significant Accounting Policies (Details)", "menuCat": "Details", "order": "16", "role": "http://www.gologiq.com/role/SignificantAccountingPoliciesDetails", "shortName": "Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P04_01_2022To04_01_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_27_2022To01_27_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtConversionDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1017 - Disclosure - Related Party Transactions (Details)", "menuCat": "Details", "order": "17", "role": "http://www.gologiq.com/role/RelatedPartyTransactionsDetails", "shortName": "Related Party Transactions (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_27_2022To01_27_2022", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtConversionDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockParOrStatedValuePerShare", "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockParOrStatedValuePerShare", "reportCount": 1, "unitRef": "Unit_USD_per_Share", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1018 - Disclosure - Business Combination (Details)", "menuCat": "Details", "order": "18", "role": "http://www.gologiq.com/role/BusinessCombinationDetails", "shortName": "Business Combination (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn02_28_2023_CreateAppPlatformMemberusgaapFiniteLivedIntangibleAssetsByMajorClassAxis", "decimals": "0", "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1019 - Disclosure - Business Combination (Details) - Schedule of the fair value of assets acquired assumed", "menuCat": "Details", "order": "19", "role": "http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed", "shortName": "Business Combination (Details) - Schedule of the fair value of assets acquired assumed", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "ix:continuation", "div", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsNet", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1002 - Statement - Balance Sheets", "menuCat": "Statements", "order": "2", "role": "http://www.gologiq.com/role/BalanceSheets", "shortName": "Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1020 - Disclosure - Stockholder's Equity (Details)", "menuCat": "Details", "order": "20", "role": "http://www.gologiq.com/role/StockholdersEquityDetails", "shortName": "Stockholder's Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_07_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1021 - Disclosure - Subsequent Events - Additional information (Detail)", "menuCat": "Details", "order": "21", "role": "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail", "shortName": "Subsequent Events - Additional information (Detail)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "div", "div", "ix:continuation", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_07_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1003 - Statement - Balance Sheets (Parentheticals)", "menuCat": "Statements", "order": "3", "role": "http://www.gologiq.com/role/BalanceSheetsParentheticals", "shortName": "Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn03_31_2023", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1004 - Statement - Statements of Operations and Comprehensive Loss", "menuCat": "Statements", "order": "4", "role": "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss", "shortName": "Statements of Operations and Comprehensive Loss", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Revenues", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1005 - Statement - Statements of Stockholder's Equity (Deficit)", "menuCat": "Statements", "order": "5", "role": "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit", "shortName": "Statements of Stockholder's Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "PAsOn12_31_2021_CommonStockMemberusgaapStatementEquityComponentsAxis", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:SharesOutstanding", "reportCount": 1, "unique": true, "unitRef": "Unit_shares", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unitRef": "Unit_USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "1006 - Statement - Statements of Cash Flows", "menuCat": "Statements", "order": "6", "role": "http://www.gologiq.com/role/StatementsOfCashFlows", "shortName": "Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "div", "td", "tr", "table", "div", "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2022To03_31_2022", "decimals": "0", "lang": null, "name": "us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "reportCount": 1, "unique": true, "unitRef": "Unit_USD", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1007 - Disclosure - Nature of Business and Continuance of Operations", "menuCat": "Notes", "order": "7", "role": "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperations", "shortName": "Nature of Business and Continuance of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:NatureOfOperations", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1008 - Disclosure - Significant Accounting Policies", "menuCat": "Notes", "order": "8", "role": "http://www.gologiq.com/role/SignificantAccountingPolicies", "shortName": "Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "1009 - Disclosure - Related Party Transactions", "menuCat": "Notes", "order": "9", "role": "http://www.gologiq.com/role/RelatedPartyTransactions", "shortName": "Related Party Transactions", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "golq-20230331.htm", "contextRef": "P01_01_2023To03_31_2023", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 11, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Document Information [Line Items]" } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.", "label": "Document Information [Table]" } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r250" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r251" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r253" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r252" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r249" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.gologiq.com/role/CoverPage" ], "xbrltype": "normalizedStringItemType" }, "golq_AggregatePurchasePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Aggregate purchase per share.", "label": "Aggregate Purchase Per Share", "terseLabel": "Aggregate purchase per share (in Dollars per share)" } } }, "localname": "AggregatePurchasePerShare", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "golq_BusinessCombinationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Line Items]" } } }, "localname": "BusinessCombinationDetailsLineItems", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "golq_BusinessCombinationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination (Details) [Table]" } } }, "localname": "BusinessCombinationDetailsTable", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "golq_BusinessCombinationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Business combination.", "label": "Business Combination [Member]" } } }, "localname": "BusinessCombinationMember", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "domainItemType" }, "golq_ChangesInOperatingAssetsAndLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes In Operating Assets And Liabilities Abstract", "terseLabel": "Changes in Operating Assets and Liabilities:" } } }, "localname": "ChangesInOperatingAssetsAndLiabilitiesAbstract", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "golq_CostsArisingFromTransitionalArrangements": { "auth_ref": [], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Costs Arising from transitional arrangements.", "label": "Costs Arising from transitional arrangements", "terseLabel": "Arising from transitional arrangements and carve out assumptions on allocation of CreateApp and GoLogiq costs from Logiq, Inc. to GoLogiq" } } }, "localname": "CostsArisingFromTransitionalArrangements", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "golq_CreateAppPlatformMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Create app platform.", "label": "Create App platform [Member]" } } }, "localname": "CreateAppPlatformMember", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "golq_FinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Financing Activities.", "label": "Financing Activities [Abstract]", "terseLabel": "FINANCING ACTIVITIES" } } }, "localname": "FinancingActivitiesAbstract", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "golq_IncreaseDecreaseInIssuanceOfSharesForServiceReceived": { "auth_ref": [], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in issuance of shares for service received.", "label": "Increase Decrease In Issuance Of Shares For Service Received", "terseLabel": "Issuance of shares for service received" } } }, "localname": "IncreaseDecreaseInIssuanceOfSharesForServiceReceived", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "golq_InvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Investing Activities Abstract", "terseLabel": "INVESTING ACTIVITIES" } } }, "localname": "InvestingActivitiesAbstract", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "golq_LogiqIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Logiq inc.", "label": "Logiq Inc [Member]" } } }, "localname": "LogiqIncMember", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "golq_NatureofBusinessandContinuanceofOperationsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Business and Continuance of Operations (Details) [Line Items]" } } }, "localname": "NatureofBusinessandContinuanceofOperationsDetailsLineItems", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "stringItemType" }, "golq_NatureofBusinessandContinuanceofOperationsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Business and Continuance of Operations (Details) [Table]" } } }, "localname": "NatureofBusinessandContinuanceofOperationsDetailsTable", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "stringItemType" }, "golq_NatureofBusinessandContinuanceofOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Business and Continuance of Operations [Abstract]" } } }, "localname": "NatureofBusinessandContinuanceofOperationsLineItems", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperations" ], "xbrltype": "stringItemType" }, "golq_NatureofBusinessandContinuanceofOperationsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Nature of Business and Continuance of Operations [Table]" } } }, "localname": "NatureofBusinessandContinuanceofOperationsTable", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperations" ], "xbrltype": "stringItemType" }, "golq_NesteggMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Nestegg.", "label": "Nestegg [Member]" } } }, "localname": "NesteggMember", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "golq_NonCashTransactionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Non Cash Transaction Abstract", "terseLabel": "NON-CASH TRANSACTION" } } }, "localname": "NonCashTransactionAbstract", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "golq_OperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Activities Abstract", "terseLabel": "OPERATING ACTIVITIES" } } }, "localname": "OperatingActivitiesAbstract", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "golq_PercentageOfCommonSharesAcquired": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of common shares acquired.", "label": "Percentage Of Common Shares Acquired", "terseLabel": "Percentage of Common Shares Acquired" } } }, "localname": "PercentageOfCommonSharesAcquired", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "golq_RelatedPartyTransactionsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Line Items]" } } }, "localname": "RelatedPartyTransactionsDetailsLineItems", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "golq_RelatedPartyTransactionsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions (Details) [Table]" } } }, "localname": "RelatedPartyTransactionsDetailsTable", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "golq_RemainingIssuanceOfPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Remaining issuance of percentage.", "label": "Remaining Issuance Of Percentage", "terseLabel": "Remaining issuance of percentage" } } }, "localname": "RemainingIssuanceOfPercentage", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "golq_ScheduleOfTheFairValueOfAssetsAcquiredAssumedAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of The Fair Value Of Assets Acquired Assumed Abstract" } } }, "localname": "ScheduleOfTheFairValueOfAssetsAcquiredAssumedAbstract", "nsuri": "http://www.gologiq.com/20230331", "xbrltype": "stringItemType" }, "golq_ShareSubscriptionsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Subscriptions Receivable Member" } } }, "localname": "ShareSubscriptionsReceivableMember", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "domainItemType" }, "golq_StockholdersEquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholder's Equity (Details) [Line Items]", "terseLabel": "Stockholder's Equity [Line Items]" } } }, "localname": "StockholdersEquityDetailsLineItems", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "golq_StockholdersEquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholder's Equity (Details) [Table]" } } }, "localname": "StockholdersEquityDetailsTable", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "golq_WorkingCapital": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of working capital.", "label": "Working Capital", "terseLabel": "Working capital" } } }, "localname": "WorkingCapital", "nsuri": "http://www.gologiq.com/20230331", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r264" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]", "terseLabel": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r264", "r276" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r9" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts Payable and Accrued Liabilities, Current", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r4", "r248" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r175", "r176", "r177", "r260", "r261", "r262", "r273" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r61", "r69", "r78", "r93", "r126", "r129", "r133", "r138", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r188", "r190", "r196", "r248", "r268", "r269", "r278" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r30" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r186", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree.", "label": "Business Acquisition, Acquiree [Domain]" } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails", "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r53", "r54", "r186", "r245", "r246" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails", "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned": { "auth_ref": [ "r57" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of equity interests (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire the entity.", "label": "Business Acquisition, Equity Interest Issued or Issuable, Value Assigned", "terseLabel": "Value of equity interests issued or issuable to acquire the entity" } } }, "localname": "BusinessAcquisitionEquityInterestIssuedOrIssuableValueAssigned", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionPercentageOfVotingInterestsAcquired": { "auth_ref": [ "r52" ], "lang": { "en-us": { "role": { "documentation": "Percentage of voting equity interests acquired at the acquisition date in the business combination.", "label": "Business Acquisition, Percentage of Voting Interests Acquired", "terseLabel": "Percentage of common stock and voting power" } } }, "localname": "BusinessAcquisitionPercentageOfVotingInterestsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r58", "r187" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "Business Combination Disclosure [Text Block]", "terseLabel": "Business Combination" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombination" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets, excluding financial assets and goodwill, that lack physical substance, having a projected indefinite period of benefit, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets", "terseLabel": "Intangible assets" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r55" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill", "terseLabel": "Goodwill" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combinations [Abstract]" } } }, "localname": "BusinessCombinationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r24", "r76", "r240" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 10.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r25" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents, Policy [Policy Text Block]", "terseLabel": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r20", "r24", "r29" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, End of Period", "periodStartLabel": "Cash, Beginning of Period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect": { "auth_ref": [ "r20", "r59" ], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; excluding effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect", "totalLabel": "Change in Cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r79", "r80", "r81", "r93", "r108", "r109", "r111", "r113", "r116", "r117", "r138", "r149", "r151", "r152", "r153", "r156", "r157", "r159", "r160", "r162", "r166", "r172", "r196", "r239", "r254", "r257", "r263" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails", "http://www.gologiq.com/role/StockholdersEquityDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Aggregate number of common shares reserved for future issuance.", "label": "Common Stock, Capital Shares Reserved for Future Issuance", "verboseLabel": "Common Stock, Capital Shares Reserved for Future Issuance" } } }, "localname": "CommonStockCapitalSharesReservedForFutureIssuance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r260", "r261", "r273" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit", "http://www.gologiq.com/role/StockholdersEquityDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockNoParValue": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Face amount per share of no-par value common stock.", "label": "Common Stock, No Par Value", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockNoParValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock par value (in Dollars per share)", "verboseLabel": "Common stock per share price (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheetsParentheticals", "http://www.gologiq.com/role/BusinessCombinationDetails", "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "definitionGuidance": "Common Stock Shares Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheetsParentheticals", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r3", "r45" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r3", "r248" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock Authorized: 200,000,000 shares of common stock, $0.001 par value 40,444,083 and 5,731,000 shares issued and outstanding as of December 31, 2022 and December 31, 2021, respectively", "verboseLabel": "Fair value of common stock" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets", "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for comprehensive income.", "label": "Comprehensive Income, Policy [Policy Text Block]", "terseLabel": "Comprehensive Loss" } } }, "localname": "ComprehensiveIncomePolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r17", "r93", "r138", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r196", "r268" ], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 4.0, "parentTag": "us-gaap_GrossProfit", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of Service" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Description", "terseLabel": "Share conversion basis" } } }, "localname": "DebtConversionDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r0", "r1", "r46", "r62", "r63", "r66", "r68" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt Instrument, Description", "terseLabel": "Basis description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r67" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Issuance of percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DefinedBenefitPlanNumberOfSharesOfEquitySecuritiesIssuedByEmployerAndRelatedPartiesIncludedInPlanAssets": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of employer stock in which defined benefit plan asset is invested. Includes, but is not limited to, stock issued or managed by related party of employer.", "label": "Defined Benefit Plan, Plan Assets, Employer, Related Party, Number of Shares", "terseLabel": "Common stock issued (in Shares)" } } }, "localname": "DefinedBenefitPlanNumberOfSharesOfEquitySecuritiesIssuedByEmployerAndRelatedPartiesIncludedInPlanAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_DueToOtherRelatedPartiesNoncurrent": { "auth_ref": [ "r11", "r60", "r259" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount payable from related parties classified as other, due after one year or the normal operating cycle, if longer.", "label": "Due to Other Related Parties, Noncurrent", "terseLabel": "Due to related parties" } } }, "localname": "DueToOtherRelatedPartiesNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r89", "r99", "r100", "r101", "r102", "r103", "r107", "r108", "r111", "r112", "r113", "r114", "r194", "r195", "r231", "r233", "r241" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic and Diluted Net (Loss) per Common Share (in Dollars per share)" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r31", "r32" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share, Policy [Policy Text Block]", "terseLabel": "Loss Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r45", "r74", "r85", "r86", "r87", "r94", "r95", "r96", "r98", "r104", "r106", "r115", "r139", "r173", "r175", "r176", "r177", "r184", "r185", "r193", "r197", "r198", "r199", "r200", "r201", "r202", "r205", "r234", "r235", "r236" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit", "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_EquityInterestIssuedOrIssuableByTypeAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of equity interests that are issued or issuable in a business combination.", "label": "Equity Interest Type [Axis]" } } }, "localname": "EquityInterestIssuedOrIssuableByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_EquityInterestIssuedOrIssuableTypeDomain": { "auth_ref": [ "r57" ], "lang": { "en-us": { "role": { "documentation": "Name of equity interest issued or issuable to acquire an entity in a business combination.", "label": "Equity Interest Issued or Issuable, Type [Domain]" } } }, "localname": "EquityInterestIssuedOrIssuableTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurements" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r145", "r146", "r147", "r148", "r216", "r217" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosure": { "auth_ref": [ "r274" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.", "label": "Finite-Lived Intangible Assets, Fair Value Disclosure", "terseLabel": "Finite lived intangible assets, fair value disclosure" } } }, "localname": "FiniteLivedIntangibleAssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r39", "r42" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r43", "r216" ], "calculation": { "http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed": { "order": 1.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "terseLabel": "Intangible assets, net" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1": { "auth_ref": [ "r216" ], "lang": { "en-us": { "role": { "documentation": "Remaining amortization period of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Finite-Lived Intangible Assets, Remaining Amortization Period", "terseLabel": "Straight-line method term" } } }, "localname": "FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": { "auth_ref": [ "r204" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.", "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]", "terseLabel": "Foreign Currency Translation" } } }, "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r18" ], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 6.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r77", "r140", "r230", "r244", "r248", "r266", "r267" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 12.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r143", "r144", "r244" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "terseLabel": "Goodwill and Intangible Assets" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": { "auth_ref": [ "r37", "r40" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.", "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]", "terseLabel": "Intangible assets" } } }, "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillGross": { "auth_ref": [ "r141", "r142", "r244" ], "calculation": { "http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed": { "order": 2.0, "parentTag": "us-gaap_IntangibleAssetsGrossExcludingGoodwill", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill, Gross", "terseLabel": "Goodwill" } } }, "localname": "GoodwillGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed" ], "xbrltype": "monetaryItemType" }, "us-gaap_GrossProfit": { "auth_ref": [ "r16", "r93", "r126", "r128", "r132", "r134", "r138", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r196", "r243", "r268" ], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.", "label": "Gross Profit", "totalLabel": "Gross Profit" } } }, "localname": "GrossProfit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r84", "r178", "r179", "r180", "r181", "r182", "r183" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Tax, Policy [Policy Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r22" ], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r22" ], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expense and deposits" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsGrossExcludingGoodwill": { "auth_ref": [ "r77" ], "calculation": { "http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.", "label": "Intangible Assets, Gross (Excluding Goodwill)", "totalLabel": "Net assets acquired" } } }, "localname": "IntangibleAssetsGrossExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetailsScheduleOfTheFairValueOfAssetsAcquiredAssumed" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r38", "r41" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 11.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r10", "r93", "r138", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r189", "r190", "r191", "r196", "r242", "r268", "r278", "r279" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total Liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r8", "r64", "r71", "r248", "r258", "r265", "r275" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "TOTAL LIABILITIES AND STOCKHOLDER'S FUNDS" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_NatureOfOperations": { "auth_ref": [ "r118", "r123" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.", "label": "Nature of Operations [Text Block]", "terseLabel": "Nature of Business and Continuance of Operations" } } }, "localname": "NatureOfOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r90" ], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net Cash Provided by (Used in) Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r90" ], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net Movement in Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r20", "r21", "r23" ], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net Cash (Used in) Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r15", "r23", "r65", "r72", "r75", "r82", "r83", "r87", "r93", "r97", "r99", "r100", "r101", "r102", "r105", "r106", "r110", "r126", "r128", "r132", "r134", "r138", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r195", "r196", "r243", "r268" ], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 }, "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "terseLabel": "Net (Loss) for the Period", "totalLabel": "Net (Loss) and Comprehensive (Loss)", "verboseLabel": "Net (loss) for the year" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows", "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss", "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OperatingExpenses": { "auth_ref": [], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 5.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.", "label": "Operating Expenses", "totalLabel": "Total Operating Expenses" } } }, "localname": "OperatingExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Operating Expenses [Abstract]", "terseLabel": "Operating Expenses" } } }, "localname": "OperatingExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "stringItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r126", "r128", "r132", "r134", "r243" ], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "(Loss) from Operations", "verboseLabel": "Operating losses" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails", "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r2", "r159" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred Stock, Par or Stated Value Per Share" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r2", "r159" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheetsParentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding", "verboseLabel": "Preferred Stock, Shares Outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheetsParentheticals", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r2", "r248" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock Authorized: 10,000,000 shares of preferred stock, 2,000,000 shares issued and outstanding as of December 31, 2022 and December 31, 2021 nil, respectively" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromOtherDebt": { "auth_ref": [ "r19" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from debt classified as other.", "label": "Proceeds from Other Debt", "terseLabel": "Aggregate purchase price" } } }, "localname": "ProceedsFromOtherDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromRepaymentsOfRelatedPartyDebt": { "auth_ref": [], "calculation": { "http://www.gologiq.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from long-term debt by a related party. Related parties, include, but are not limited to, affiliates, owners or officers and their immediate families, and pension trusts.", "label": "Proceeds from (Repayments of) Related Party Debt", "terseLabel": "Due from related party" } } }, "localname": "ProceedsFromRepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r174", "r208", "r209" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r174", "r208", "r218", "r219", "r220", "r221", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r277" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r206", "r207", "r209", "r210", "r211" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Related Party Transactions" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_ResearchAndDevelopmentExpense": { "auth_ref": [ "r51", "r73", "r280" ], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 8.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.", "label": "Research and Development Expense", "terseLabel": "Research and development" } } }, "localname": "ResearchAndDevelopmentExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r5", "r47", "r70", "r237", "r238", "r248" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 9.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit", "verboseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets", "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r74", "r94", "r95", "r96", "r98", "r104", "r106", "r139", "r175", "r176", "r177", "r184", "r185", "r193", "r234", "r236" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r88", "r93", "r124", "r125", "r127", "r130", "r131", "r135", "r136", "r137", "r138", "r149", "r150", "r151", "r152", "r153", "r154", "r155", "r156", "r157", "r196", "r232", "r268" ], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 3.0, "parentTag": "us-gaap_GrossProfit", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "terseLabel": "Service Revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNameOfTransactionDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.", "label": "Sale of Stock [Domain]" } } }, "localname": "SaleOfStockNameOfTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Preferred stock par value (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r56" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]", "terseLabel": "Schedule of the fair value of assets acquired assumed" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss": { "order": 7.0, "parentTag": "us-gaap_OperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Selling and Marketing Expense", "terseLabel": "Sales and marketing" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r255", "r256", "r270" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember": { "auth_ref": [ "r54" ], "lang": { "en-us": { "role": { "documentation": "Represents the aggregation and reporting of combined amounts of individually immaterial business combinations that were completed during the period.", "label": "Series of Individually Immaterial Business Acquisitions [Member]", "terseLabel": "Business Combination [Member]" } } }, "localname": "SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreed-upon price for the exchange of the underlying asset relating to the share-based payment award.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Exercise Price", "terseLabel": "Share price" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r247" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized", "terseLabel": "Number of shares authorized for issuance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "auth_ref": [ "r49" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "terseLabel": "Share-Based Payment Award, Shares Issued in Period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "auth_ref": [ "r272" ], "lang": { "en-us": { "role": { "documentation": "Percentage of vesting of award under share-based payment arrangement.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "terseLabel": "Percentage of vesting of award" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "percentItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r30", "r91" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r79", "r80", "r81", "r93", "r108", "r109", "r111", "r113", "r116", "r117", "r138", "r149", "r151", "r152", "r153", "r156", "r157", "r159", "r160", "r162", "r166", "r172", "r196", "r239", "r254", "r257", "r263" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails", "http://www.gologiq.com/role/StockholdersEquityDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r14", "r45", "r74", "r85", "r86", "r87", "r94", "r95", "r96", "r98", "r104", "r106", "r115", "r139", "r173", "r175", "r176", "r177", "r184", "r185", "r193", "r197", "r198", "r199", "r200", "r201", "r202", "r205", "r234", "r235", "r236" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit", "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r94", "r95", "r96", "r115", "r215" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r26", "r27", "r28" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Stock Issued", "terseLabel": "Issuance of shares for services received" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r13", "r45", "r46", "r47", "r158" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities", "terseLabel": "Stock Issued During Period, Shares, Conversion of Convertible Securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan": { "auth_ref": [ "r2", "r3", "r45", "r47", "r50" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of capital stock issued (purchased by employees) in connection with an employee stock ownership plan.", "label": "Stock Issued During Period, Shares, Employee Stock Ownership Plan", "terseLabel": "Issuance of Shares for share exchange (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesIssuedForServices": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued in lieu of cash for services contributed to the entity. Number of shares includes, but is not limited to, shares issued for services contributed by vendors and founders.", "label": "Stock Issued During Period, Shares, Issued for Services", "terseLabel": "Issuance of Shares for services (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r2", "r3", "r45", "r47" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuance of Shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit", "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Shares, Other", "terseLabel": "Aggregate shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/NatureOfBusinessAndContinuanceOfOperationsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesPurchaseOfAssets": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period as part of a transaction to acquire assets that do not qualify as a business combination.", "label": "Stock Issued During Period, Shares, Purchase of Assets", "terseLabel": "Exchanged common stock (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesPurchaseOfAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockSplits": { "auth_ref": [ "r2", "r3", "r45", "r47" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of a stock split.", "label": "Stock Issued During Period, Shares, Stock Splits", "terseLabel": "Issued of aggregate shares (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockSplits", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/RelatedPartyTransactionsDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan": { "auth_ref": [ "r2", "r3", "r45", "r47", "r50" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate value of stock issued during the period as a result of employee stock ownership plan (ESOP).", "label": "Stock Issued During Period, Value, Employee Stock Ownership Plan", "terseLabel": "Issuance of Shares for share exchange" } } }, "localname": "StockIssuedDuringPeriodValueEmployeeStockOwnershipPlan", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueIssuedForServices": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued in lieu of cash for services contributed to the entity. Value of the stock issued includes, but is not limited to, services contributed by vendors and founders.", "label": "Stock Issued During Period, Value, Issued for Services", "terseLabel": "Issuance of Shares for services" } } }, "localname": "StockIssuedDuringPeriodValueIssuedForServices", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r2", "r3", "r45", "r47" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuance of Shares" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r3", "r6", "r7", "r36", "r248", "r258", "r265", "r275" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total Stockholder's Funds (Deficit)" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets", "http://www.gologiq.com/role/StatementsOfStockholderSEquityDeficit" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Stockholder's Funds (Deficit)" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Note [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r48", "r92", "r160", "r161", "r162", "r163", "r164", "r165", "r166", "r167", "r168", "r169", "r170", "r171", "r173", "r192" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Stockholder's Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_StockholdersEquityNoteSubscriptionsReceivable": { "auth_ref": [ "r2", "r3", "r6", "r44" ], "calculation": { "http://www.gologiq.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_StockholdersEquity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Note received instead of cash as contribution to equity. The transaction may be a sale of capital stock or a contribution to paid-in capital.", "label": "Stockholders' Equity Note, Subscriptions Receivable", "negatedLabel": "Share subscriptions receivable" } } }, "localname": "StockholdersEquityNoteSubscriptionsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r203", "r213" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r203", "r213" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r203", "r213" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/BusinessCombinationDetails", "http://www.gologiq.com/role/SubsequentEventsAdditionalInformationDetail" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r212", "r214" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsidiarySaleOfStockAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of sale of the entity's stock.", "label": "Sale of Stock [Axis]" } } }, "localname": "SubsidiarySaleOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StockholdersEquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r33", "r34", "r35", "r119", "r120", "r121", "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates, Policy [Policy Text Block]", "terseLabel": "Use of Estimates and Judgments" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/SignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r107", "r113" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted Average Number of Common Shares Outstanding (in Shares)" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.gologiq.com/role/StatementsOfOperationsAndComprehensiveLoss" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.23)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r123": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.1,2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r204": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "830", "URI": "https://asc.fasb.org/topic&trid=2175825", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r211": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r214": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r239": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766", "role": "http://www.xbrl.org/2003/role/exampleRef" }, "r249": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r250": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r251": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r252": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r253": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2", "role": "http://www.xbrl.org/2003/role/presentationRef" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054", "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "730", "Topic": "912", "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433", "role": "http://www.xbrl.org/2009/role/commonPracticeRef" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r30": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r48": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "25", "SubTopic": "40", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=109244457&loc=d3e16649-113920", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "730", "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r58": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682", "role": "http://fasb.org/us-gaap/role/ref/legacyRef" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794", "role": "http://www.xbrl.org/2003/role/disclosureRef" } }, "version": "2.2" } ZIP 40 0001575872-23-000819-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001575872-23-000819-xbrl.zip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end